← Back to Cadaret, Grant & Co., Inc. profile
CADARET GRANT CONTOUR WRAP FEE PROGRAM BROCHURE MARCH 2025
Cadaret, Grant & Co., Inc. (CRD 10641), brochure dated March 28, 2025. Text extracted from the firm's SEC Form ADV Part 2 brochure.
View firm on SEC ↗ · Current Form ADV (PDF) ↗
Contour Platform
Form ADV Part 2A Appendix 1
Wrap Fee Program Brochure
March 28, 2025
100 Madison Street, Suite 1300
Syracuse, NY 13202
800-288-8601
www.cadaretgrant.com
This Wrap Fee Program Brochure provides information about the qualifications and business practices of
Cadaret Grant & Co., Inc. (“Cadaret Grant”). If you have any questions about the contents of this Brochure,
please contact us at 800-288-8601. The information in this Brochure has not been approved or verified by
the United States Securities and Exchange Commission (“SEC”) or by any state securities authority. Cadaret
Grant is a registered investment adviser. Registration as an investment adviser does not imply a certain level
of skill or training.
Additional information about Cadaret Grant & Co., Inc. is available on the SEC’s website at
www.adviserinfo.sec.gov.
Rev. 03/28/2025
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Item 2 – Material Changes
Cadaret Grant filed its last annual update of the Contour Part 2A Appendix 1 Wrap Fee Program Brochure on
March 28, 2024. Since then, there have been material changes which are summarized below. For additional
details, please see the item in this Contour Part 2A Appendix 1 Wrap Fee Program Brochure referred to in the
summary below.
Item 4 – Services, Fees and Compensation
• Updated disclosures to reflect that Atria Wealth Solutions, Inc. is owned by LPL Holdings, Inc., which
is a wholly owned subsidiary of LPL Financial Holdings Inc., a publicly held company.
Item 9 – Additional Information:
• Updated Other Financial Industry Activities and Affiliations to include new financial industry
affiliations due to the change in ownership.
• Updated Disciplinary Information to include the SEC Order Instituting Administrative and Cease-
and-Desist Proceedings pursuant to Section 15(b) of the Securities Exchange Act of 1934 and Sections
203(e) and 203(k) of the Advisers Act, Making Findings, and Imposing Remedial Sanctions and a
Cease-and-Desist Order as to Cadaret Grant, issued on August 12, 2024.
• Client Referrals and Other Compensation was updated to include more information around the
arrangements Cadaret Grant and/or its Investment Adviser Representatives (IARs) enter into with
clients, third parties or other financial intermediaries for lead generation, client referrals or solicitation
for program accounts.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Item 3 – Table of Contents
Item 2 – Material Changes ............................................................................................................ 2
Item 3 – Table of Contents .......................................................................................................... 3
Item 4 – Services, Fees and Compensation ............................................................................... 5
Introductory Information............................................................................................................. 5
Services .................................................................................................................................... 5
Advisor as Portfolio Manager (“APM”)........................................................................................ 7
Fund Strategist Portfolios (“FSP”) .............................................................................................. 8
Separately Managed Accounts (“SMA”) ..................................................................................... 8
Unified Managed Accounts (“UMA”) .......................................................................................... 9
IRA Rollover Considerations .................................................................................................... 10
Fees ....................................................................................................................................... 10
Other Fees and Expenses ....................................................................................................... 15
Item 5 – Account Requirements and Types of Clients ............................................................. 19
Account Requirements ............................................................................................................ 19
Types of Clients ...................................................................................................................... 19
Item 6 – Portfolio Manager Selection and Evaluation .............................................................. 19
SMA Managers, Sub-Managers, Strategists, and Model Providers .......................................... 19
Performance Calculation ......................................................................................................... 20
Performance-Based Fees and Side-by-Side Management ....................................................... 20
Methods of Analysis, Investment Strategies and Risk of Loss .................................................. 20
Voting Client Securities ........................................................................................................... 24
Item 7 – Client Information Provided to Portfolio Managers ................................................... 24
Item 8 – Client Contact with Portfolio Managers ..................................................................... 24
Item 9 – Additional Information ................................................................................................ 24
Disciplinary Information ........................................................................................................... 24
Other Financial Industry Activities and Affiliations .................................................................... 27
Conflicts of Interest as a Broker-Dealer and Insurance Agency ................................................ 27
An IAR’s Outside Business Activities ...................................................................................... 28
Conflicts of Interest with Independent Registered Investment Advisers ............................................ 28
Conflicts of Interest as an Insurance Agency .............................................................................. 29
Code of Ethics, Participation or Interest in Client Transactions, and Personal Trading ......... 29
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Brokerage Practices ................................................................................................................ 30
Review of Accounts................................................................................................................. 37
Client Referrals and Other Compensation ............................................................................... 38
Custody .................................................................................................................................. 42
Financial Information ............................................................................................................... 42
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Item 4 – Services, Fees and Compensation
Introductory Information
Cadaret Grant & Co., Inc. (“Cadaret Grant,” “we,” or “us”), was formed in 1985 and is a Delaware corporation.
We are a wholly owned subsidiary of AWS 4, Inc., a Delaware corporation, which is a wholly owned subsidiary
of Atria Wealth Solutions, Inc., (“Atria”) a Delaware corporation, which is in turn wholly owned by LPL
Holdings, Inc., which is owned 100% by LPL Financial Holdings Inc., a publicly held company.
Cadaret Grant is registered as a broker-dealer and investment adviser with the Securities and Exchange
Commission (“SEC”) and is a member of the Financial Industry Regulatory Authority, Inc. (“FINRA”) and
Securities Investor Protection Corporation (“SIPC”). Cadaret Grant is also licensed as an insurance agency in
50 states.
Our principal business is providing a full line of services as a registered securities broker-dealer and investment
adviser. In our capacity as a broker -dealer, we are involved in the sale of securities of various types including
stocks, bonds, mutual funds, alternative investments, unit investment trusts (“UITs”), and variable annuities.
We do not sell proprietary products.
As of December 31, 2024, Cadaret Grant had regulatory assets under management of $7,671,069,034. Of that
amount, $126,965,834 was managed on a non-discretionary basis and $7,544,103,200 was managed on a
discretionary basis.
Our investment advisory services (“Advisory Services”) are made available to clients through individuals
associated with Cadaret Grant as investment adviser representatives (“IARs”). Many IARs are dually licensed
(i.e., they are licensed both as IARs and as registered representatives and offer both investment advisory and
brokerage services), which, in addition to Advisory Services, allows them to offer commission-based products.
Your IAR will disclose to you whether he or she is dually licensed and if there are any limitations on services
offered due to registrations and qualifications.
Cadaret Grant offers clients a variety of advisory programs, including the Contour advisory platform
(“Contour”), which includes both wrap fee (as described in this Contour Part 2A Appendix 1 Wrap Fee
Program Brochure (“Contour Brochure”)) and non-wrap fee programs (please see “Fees” below for an
explanation of these differences). This Contour Brochure describes the Contour platform, focusing on the
Contour wrap fee program, with certain clarifying information about the non-wrap fee option. For more
information about Cadaret Grant’s advisory services and programs other than the Contour wrap fee program,
including the Contour non-wrap fee program, please contact your IAR for a copy of our Form ADV Part 2A
brochure that describes our other services and programs or go to www.adviserinfo.sec.gov.
Cadaret Grant does not maintain physical possession of the assets of any accounts. Contour accounts are
custodied with an unaffiliated custodian designated by a client after consultation with an IAR. Custodial options
include Pershing LLC (“Pershing”), Charles Schwab & Co., Inc. (“Schwab”), and any other custodian Cadaret
Grant chooses to make available (hereinafter referred to as “Custodian”).
Services
Contour is a discretionary advisory platform (“Platform”) sponsored by Cadaret Grant, offering both wrap fee
and non-wrap fee options. Cadaret Grant has entered into an agreement with Envestnet Asset Management,
Inc. (“Envestnet”), a registered investment adviser, to provide administrative services for the Platform and
Contour accounts. Cadaret Grant has designated Custodians to execute and clear transactions, custody assets,
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
and deliver statements and confirmations to you, as applicable. Neither Envestnet nor Custodians are affiliated
with Cadaret Grant.
Additionally, Envestnet provides an electronic performance reporting system which permits an IAR to create
performance reports on demand in addition to preparing quarterly performance reports that will be provided
to you.
Contour is comprised of multiple Platform program options:
Allowable Assets
Program
Options
Program
Description
Transaction
Fees
Minimum
Account
Size
$25,000
Traditional
discretionary IAR
directed program
Wrap or Non-
Wrap
Mutual funds, ETFs,
options (limited to
covered calls and
purchases), fee based
UITs, equities, bonds,
structured notes, and fee-
based annuities
Advisor as
Portfolio
Manager
(“APM”)
ETFs, mutual funds and
money market funds
As low as
$2,000
(manager
dependent)
Fund
Strategist
Portfolios
(“FSP”)
Discretionary
advisory program
comprised of ETF
and/or Mutual
Fund Models
Wrap
$100,000
ETFs, exchange traded
notes and exchange traded
vehicles, mutual funds,
equities and bonds
Wrap
Separately
Managed
Accounts
(“SMA”)
Separately
managed
account
program using
third-party
investment
advisers
$100,000
ETFs, exchange traded
notes and exchange traded
vehicles, mutual funds,
fee-based UITs, annuities,
equities and bonds
Wrap
Unified
Managed
Accounts
(“UMA”)
Unified
managed
account
program with
Model
Providers,
Sub- Managers
and Other
Investments
Your IAR will confer with you to determine your financial needs and objectives and gather your client profile
and risk tolerance information to complete a Statement of Investment Selection (“SIS”). The information
gathered from the risk tolerance questionnaire (“RTQ”), or an approved financial planning tool, assists in
determining a recommended allocation of your assets into an asset allocation model fitting one of seven
investment profiles: Capital Preservation, Conservative, Conservative Growth, Moderate, Moderate Growth,
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Growth, or Aggressive. Your IAR will obtain your written consent to change your investment profile risk
tolerance. Your IAR will assist you in selecting one of the four program options to implement the portfolio.
Your IAR will create a proposal (“Proposal”) including your investment profile questionnaire responses,
selected program option(s), and applicable fees. You, your IAR, and Cadaret Grant will enter into a Contour
Platform Account Agreement (“Contour Agreement”) outlining your participation in the Platform.
Contour accounts are managed on a limited discretionary basis to invest, reinvest, and otherwise deal with
Platform Assets with discretion granted to: (a) the IAR in APM and the FSP Program; (b) each SMA Manager
in the SMA Program; (c) each Sub-Manager for assets allocated to it, and (d) to IAR for assets allocated to
Other Investments according to Client’s Investment Profile and to select and allocate assets among Model
Providers and Sub-Managers. Such discretionary authority allows the authorized party to make all investment
decisions with respect to the Account and, when it deems appropriate and without prior consultation with
Client, to buy, sell, exchange, convert, and otherwise trade Platform Assets. In addition, with respect to the
UMA and FSP Programs, Client hereby grants (a) IAR limited discretionary authority that IAR may delegate to
Envestnet in its capacity as overlay manager subject to the terms set forth above; and (b) the IAR limited
discretionary authority to replace Model Providers and Sub-Managers (UMA Program only) in accordance with
the Client’s previously determined client profile and risk tolerance information.
Your IAR has limited discretion to change your investment strategies, Model Providers and/or Sub-Managers
within the same profile risk tolerance to a lower tolerance without your approval so long as there is no fee
increase; however, to increase your risk tolerance or fees, your IAR will obtain your written consent.
Advisor as Portfolio Manager (“APM”)
APM is a program within the Platform designed to provide investment advice through an IAR for a fee based
on the value of your Platform assets. Currently, APM is the only Contour program we offer as both wrap fee
or non-wrap fee. Acting under the Contour Agreement, your IAR establishes an account at a Custodian for the
purpose of creating a portfolio to be managed by your IAR on a discretionary basis. Envestnet has no discretion
over assets managed in the APM and is not providing investment advice to you.
At the inception of the relationship, your IAR uses the investment profile based on your RTQ or a firm
approved financial planning tool to select portfolio securities based on an asset allocation model. Your IAR will
enter transaction orders consistent with your investment profile, risk tolerance, and objectives. Currently, the
list of approved investments for the APM includes mutual funds, exchange traded funds (“ETFs”), options
(limited to covered calls and purchases), fee- based unit investment trusts (“UITs”), equities, bonds, structured
products, and other securities.
If your IAR is dually licensed with Cadaret Grant, your IAR’s selection of investments in APM will be limited
by the FINRA registrations held by your IAR. If your IAR only holds the Series 6, Investment Company and
Variable Contracts Products registration, your IAR will implement the IAR-directed model portfolio strategy
using only mutual funds and/or fee-based annuities.
Because of the account’s discretionary nature, your IAR has full judgment over the selection and amount of
investments to be purchased or sold in the account, without obtaining your prior consent or approval. Once a
portfolio is constructed, your IAR monitors the account and rebalances the portfolio as changes in market
conditions and client circumstances warrant.
For additional information about the non-wrap fee version of this program, please see our Form ADV Part 2A
Brochure.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Fund Strategist Portfolios (“FSP”)
FSP, a wrap fee only program, is designed to provide discretionary investment advice through a roster of third-
party strategists, managed ETF and/or mutual fund models. The model portfolios are managed for a fee based
on the value of your Platform assets. Acting under the Contour Agreement, your IAR establishes an account at
a Custodian to be invested in one of the ETF or mutual fund models available in the program. Your responses
to the RTQ or financial plan will assist in determining which of the models is appropriate based on your
investment objectives, time horizon and risk tolerance.
Once an asset allocation model has been selected, you will grant your IAR limited discretionary authority so
that IAR may delegate to Envestnet (in its capacity as overlay manager) discretionary authority to:
•
Invest the assets in the Program account in accordance with the selected ETF or mutual fund model
strategies;
• Make changes to the asset allocations, as deemed appropriate; and
• Rebalance the assets when needed.
Changes in the asset allocation model, which include adding, removing, or replacing securities, are made based
on a variety of factors as dictated by the strategist, including but not limited to, changes in economic, financial,
market, and/or political conditions.
At the inception of an account, FSP assets are invested in ETF and/or mutual fund models determined in
accordance with set target percentages of the total assets in the account. Thereafter, as markets fluctuate and
values change, amounts originally allocated to an ETF and/or mutual fund model will either exceed or fall
below the original target allocations. Envestnet will periodically adjust model allocations back to the original
asset targets, or “rebalance” the account. However, models are not rebalanced constantly, and asset allocations
will drift away from their original target percentages before Envestnet, within its authority and judgment, brings
those allocations back in line with the original percentages.
The selected strategist is responsible for monitoring the models and rebalancing each model as changes in
market conditions warrant. Envestnet trades and rebalances FSP accounts based solely on strategist models and
directives.
The tax consequences of ETF ownership differ from those of mutual funds. Held in taxable accounts, ETFs
can be more tax efficient compared to traditional mutual funds. Generally, holding an ETF in a taxable account
will generate less tax liabilities than if you held a similarly structured mutual fund in the same account. If you
are concerned with tax efficiency, you should discuss this with your IAR or your tax advisor.
Separately Managed Accounts (“SMA”)
SMA, a wrap fee only program, is a program designed to provide investment advice through other investment
advisers (“SMA Managers”) for a fee based on the value of your Platform assets. SMA Managers have been
selected by Cadaret Grant to provide portfolio investment management services and have entered into a
participation agreement with Envestnet. Each selected SMA Manager has discretion to invest the assets in
exchange traded products such as ETFs, exchange traded notes and exchange traded vehicles, mutual funds,
equities, bonds, and other securities.
At the inception of the relationship, the IAR uses the information from your RTQ or financial plan to
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
recommend an SMA Manager whose strategies are appropriate for you based on your objectives and profile.
Acting under the Contour Agreement, the IAR establishes an account at a Custodian for the purpose of creating
a portfolio to be managed by an SMA Manager on a discretionary basis. The SMA Manager manages the account
according to the SMA Manager’s strategies and your reasonable restrictions, if any. The SMA Manager can, in
its sole discretion, decline to accept a client for any reason.
Because of the account’s discretionary nature, the SMA Manager has full authority over the selection and
amount of investments to be purchased or sold in the account, without obtaining your prior consent or
approval. Once a model portfolio is constructed, the SMA Manager monitors the account and rebalances the
portfolio as changes in market conditions and client circumstances warrant.
For additional information about an SMA Manager please see their Form ADV Part 2A Brochure.
Unified Managed Accounts (“UMA”)
UMA, a wrap fee only program, is designed to provide you with access to various investment strategies,
including model strategies provided by one or more model providers (“Model Providers”) and other available
investments, such as ETFs, stocks and mutual funds (“Other Investments”) via a single Unified Managed
Account (“UMA”). Individual Sub-Managers who manage and place trades for the sleeves (portion of an
account) allocated to the Sub-Manager are an available option for certain strategies if selected and designated
in the SIS. Model Providers and Sub-Managers are selected for UMA participation in Contour by Cadaret Grant
and enter into a contractual relationship with Envestnet. Your IAR is granted authority to select and allocate
assets among the Model Providers and Sub-Managers according to your risk tolerance. Your IAR is also granted
limited discretionary authority to invest, reinvest and otherwise deal with assets allocated to Other Investments
in your UMA according to your investment objectives, risk tolerance, and time horizon determined by the RTQ
or financial plan.
Cadaret Grant has entered into an agreement with Envestnet to act as the overlay manager for UMA by
implementing trade orders and periodically updating and rebalancing each Model Portfolio pursuant to the
direction of the Model Provider and IAR. Envestnet is granted limited discretionary trading authority with
respect to assets in your UMA based on the selected models; to implement model changes; and to rebalance
accounts pursuant to target allocations and program trading parameters established by Cadaret Grant.
Envestnet will allocate assets across the investment choices available in UMA, in a manner consistent with your
instructions, or in the case of Other Investments, your IAR’s instructions, without regard to Envestnet’s own
assessment of such investment choices in circumstances where Envestnet has the authority to recommend or
select them. No allocation of your assets to a particular model strategy or Other Investment should be
considered an approval or endorsement by Envestnet of such model strategy or Other Investment.
When a Model Provider makes a change to a model strategy, Envestnet will implement changes to the UMA
accounts at its sole discretion. Except as described below, with respect to such changes, Envestnet’s sole
authority with respect to individual security selection is to carry out the client’s or IAR’s directions through
implementation of the model portfolios provided by the model providers (“Model Portfolios”). Envestnet does
not make any individual security decision on a client’s behalf other than such decisions necessary to implement
changes to the Model Portfolios, or if applicable to reject any or all changes to a model strategy. Envestnet and
Cadaret Grant retain the authority to terminate or change Model Providers and to remove or replace Other
Investments from the UMA. Assets from a removed or modified model strategy can be automatically
reallocated for investment among the other models currently held within a UMA. Envestnet is authorized to
allocate assets from an unavailable Other Investment to cash except as otherwise directed by your IAR. This
replacement process will be subject to the usual and customary settlement procedures and can have tax
consequences.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
For additional information about an SMA Manager, Model Provider, or Sub-Manager, please refer to their
Form ADV Part 2A Brochure.
Envestnet also provides optional overlay services for an additional fee related to specific client objectives that
could include tax management, ESG or socially responsible screening, or other portfolio customization to be
outlined on the SIS.
Envestnet’s Portfolio Consulting Group, Envestnet PMC™, is a Model Provider for the UMA. Envestnet PMC
acts in the same capacity as other Model Providers and creates Model Portfolios based on its proprietary
research.
Cadaret Grant and your IAR are responsible for gathering client information; selecting Model Providers and
Sub-Managers, Model Portfolios, and Other Investments; and determining if one or more Model Portfolio(s)
or Other Investments selected are suitable for the client. Envestnet can choose not to accept a UMA client in
its sole discretion.
IRA Rollover Considerations
If you decide to roll assets out of a retirement plan into a Contour individual retirement account (“IRA”),
Cadaret Grant and your IAR have a financial incentive to recommend that you invest those assets in Contour,
because Cadaret Grant and your IAR will be paid on those assets, for example, through advisory fees. You
should be aware that such fees likely will be higher than those you pay through your plan, and there can be
custodial and other maintenance fees.
The following fiduciary acknowledgement applies only when our IAR (i) provides investment advice to
participants in or the fiduciaries of ERISA-covered retirement plans and to owners of IRAs, and (ii)
recommends to participants in ERISA-covered retirement plans or owners of IRAs to make a rollover to an
IRA.
When we provide investment advice to you regarding your retirement plan account or IRA, we are fiduciaries
within the meaning of Title I of ERISA and/or the Internal Revenue Code, as applicable, which are laws
governing retirement accounts. Fiduciary status for this purpose does not necessarily mean we are acting as
fiduciaries for purposes of other applicable laws. This acknowledgement of fiduciary status does not confer
contractual rights or obligations on you, Cadaret Grant, or the IAR.
Fees
The Contour Program is offered as either an account with separate advisory fees and transaction charges (“Non-
Wrap Fee”), or as an account where no separate transaction charges apply, and a single fee is paid for all advisory
services and transactions (“Wrap Fee”).
The Contour APM program is offered under both Wrap and Non-Wrap Fee arrangements. The FSP, SMA,
and UMA Programs are only offered under Wrap Fee arrangements. If you select the Wrap Fee option, you
will pay a single account fee that is inclusive of ticket charges for the purchase and sale of securities. Please
consider that depending upon the level of the account fee charged, the amount of portfolio activity in your
account, the value of services that are provided under the program, and other factors, the account fee may or
may not exceed the aggregate cost of such services if they were to be provided separately. Our policy and
procedures are designed to ensure our IARs recommend Wrap Fee advisory accounts only for actively managed
accounts. The Wrap Fee option offers a bundled charge that is inclusive of transactional (i.e., trading) costs and
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
is meant to be utilized by investors who have an intention to actively trade their account. A Non-Wrap Fee
account is generally more cost-effective for you if you do not intend to actively trade your account. While there
is no precise determinant for an actively traded account, if you are engaging in a small number of transactions
per year, you should discuss in detail with your IAR if a wrap-account is appropriate for your needs. Please see
our Form ADV Part 2A Brochure for more information on Non-Wrap Fee accounts.
The fees for participation in Contour are based on an annual percentage of your Platform assets. The Total Fee
is comprised of three components: (a) the Program Fee, (b) the Advisory Fee, and (c) if applicable, the
Manager(s) Fee. The Manager Fee applies in the FSP, SMA, and UMA programs, but no Manager Fee is
included in the APM program.
The Program Fee includes execution, clearing, custody, and Cadaret Grant, Envestnet, and Custodian fees for
Wrap Fee accounts when applicable. The Program Fee is assessed in each of the program options and is non-
negotiable. A discounted Program Fee is available for certain IARs that meet the qualifications. The discount
will be based upon the aggregated assets under management from all clients your IAR and their branch office
maintains in all Cadaret Grant sponsored advisory programs. The discount ranges can be a partial or full
reduction of the Program Fee. If your IAR receives a discounted Program Fee, your IAR’s compensation will
increase or decrease by the amount of the discount received, but your Total Fee and cost will remain unchanged.
The Advisory Fee compensates your IAR for assisting in the design, implementation, and ongoing monitoring
of your investment plan. The Advisory Fee is negotiated between you and your IAR but will not exceed 2.25%
in APM and 2.00% in FSP, SMA and UMA, except in connection with annuity subaccount management in
APM, the Advisory Fee will not exceed 1%. The Advisory Fee charged depends upon a number of factors
including the amount of the assets under management, the nature and extent of other account relationships
between you and your IAR, the nature and complexity of the model portfolios, and other factors that the IAR
deems relevant. The Advisory Fee you negotiate will be different than the fees your IAR negotiates with other
clients or the fees other IARs negotiate with other clients for similar services.
Manager Fees apply in the FSP, SMA, and UMA. The Manager Fee in the SMA and UMA varies by the selected
SMA Manager, Sub-Manager or Model Provider and ranges between 0.00% and 0.75% of your Platform Assets.
In the UMA, if your account has more than one Model Provider or Sub-Manager, the effective Manager Fee
will be a blend of all Model Providers’ and/or Sub- Managers’ fees weighted by the dollar amount invested in
each Model Portfolio. SMA Managers or Model Providers who charge no, or a nominal fee are typically
compensated by advisory fees from the propriety funds the SMA Managers or Model Providers include in their
models. In the FSP, the Manager Fee ranges from 0% to 0.50% depending on the portfolio selected. Manager
Fees are non-negotiable.
The Total Fee is billed and collected monthly or quarterly in advance as noted on the SIS. For accounts billed
quarterly, the Total Fee is calculated at the beginning of each calendar quarter based on the fair market value of
your Platform assets, including money market funds, interest, and reinvested dividends in the account, on the
last business day of the prior calendar quarter. For accounts billed monthly, the Total Fee is calculated at the
beginning of each month based on the fair market value of your Platform assets, including money market funds,
interest, and reinvested dividends in the account, on the last business day of the prior calendar month. The
Custodian determines fair market value for fee calculation purposes.
Fees are automatically deducted from your account, or from another billable account as directed by you. The
first payment is prorated based on the number of calendar days in the billing period. If you invest or withdraw
$10,000 or more in the account after the first day of a billing period, a prorated fee or rebate is calculated on
each eligible deposit or withdrawal with adjustments applied the subsequent month. If the account is terminated
prior to the end of the billing period, a pro rata portion of the Total Fee will be credited (refunded) to you. The
fees deducted, including the dates and amounts, are reflected on the statements sent by Custodian. You should
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
review those statements and the fees deducted. Any questions on the fees deducted from your account should
be directed to your IAR, or you may contact us at the number on the cover page of this Brochure.
If you have more than one Platform account, your accounts can be “householded” aggregating your accounts
for fee calculation purposes, which can help you qualify for a lower fee. A “household” is generally a group of
accounts having the same address of record or same Social Security number. Individual Retirement Accounts
(“IRAs”), SIMPLE IRAs and other personal retirement accounts generally can be combined for householding
purposes; however, other retirement plan accounts subject to ERISA and charitable remainder trusts cannot be
aggregated. Households are established through the IAR and must be requested by the client. Neither Cadaret
Grant nor our IARs are responsible for identifying eligible accounts. A client is responsible for determining if
they have eligible accounts and ensuring those accounts remain eligible. Cadaret Grant and our IARs earn higher
fees if clients elect not to household eligible accounts where available. Clients should discuss the program fee
and any potential fee reduction available through householding with their IAR.
APM Fee Schedule (Wrap Fee Option)
Total Fee = Advisory Fee + Program Fee
Platform Assets
APM
Program
Fee
Maximum
Allowable
Advisory
Fee*
First $250,000
2.25%
0.20%
Next $250,000
2.25%
0.17%
Next $250,000
2.25%
0.15%
Next $250,000
2.25%
0.13%
0.10%
Next $1,000,000
2.00%
Next $3,000,000
1.75%
0.090%
Assets above
0.070%
1.50%
$5,000,000
* The maximum allowable advisory fee for annuity subaccount management in APM is 1%.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
APM Fee Schedule (Non-Wrap Fee Option)
Total Fee = Advisory Fee + Program Fee
APM Program Fee
Platform Assets
Maximum
Allowable
Advisory
Fee*
Schwab
as
Custodian
Pershing
as
Custodian
First $250,000
2.25%
0.15%
0.18%
Next $250,000
2.25%
0.13%
0.16%
Next $250,000
2.25%
0.11%
0.13%
Next $250,000
2.25%
0.09%
0.11%
0.07%
0.09%
Next $1,000,000
2.00%
Next $3,000,000
1.75%
0.05%
0.06%
Assets above
0.04%
0.05%
1.50%
$5,000,000
* The maximum allowable advisory fee for annuity subaccount management in APM is 1%.
Transaction Charges for Non-Wrap Accounts
In addition to the asset management fees noted above you will pay transaction charges for all trades effected in
a Non-Wrap Fee Contour APM account. We markup the transaction charges that Pershing charges us for Non-
Wrap Fee Contour APM accounts custodied with Pershing, which is a source of additional revenue for Cadaret
Grant. Although there are a number of factors considered in determining which custodian to use, the
transaction charges associated with trades in a Non-Wrap Fee Contour APM account custodied at Pershing are
higher than the transaction charges for a Non-Wrap Fee Contour APM account custodied at Schwab. The more
transactions a client enters into, the more compensation we receive. This represents a conflict of interest due
to the fact that we have a financial incentive to establish Non-Wrap Fee Contour APM accounts with Pershing
rather than Schwab because of the additional revenue we receive. This revenue, however, is retained by Cadaret
Grant and is not shared with your IAR, so your IAR does not have a financial incentive to recommend you
open a Non-Wrap Fee Contour APM account custodied with Pershing rather than Schwab or engage in
frequent transactions.
Please
refer
to
the Fee Schedule published
in
the disclosure section of our website at
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
cadaretgrant.com/disclosures/ for a detailed schedule of transaction fees and other brokerage costs as well as
for a better understanding of where we receive additional compensation.
Certain no-load or load at net asset value (“NAV”) mutual funds are available for purchase, sale, or exchange
without incurring transaction costs. These funds are offered through the Custodian’s no transaction fee
programs. Certain exchange-traded funds are also available through the Custodian’s no transaction fee
programs.
FSP, SMA, UMA Fee Schedule
Total Fee = Advisory Fee + Program Fee + Manager Fee (if applicable)
Program
Fee
Platform Assets
Maximum
Allowable
Advisory
Fee
SMA
UMA
FSP
0.26% -0.28%
First $250,000
2.00%
0.30%
0.24%
0.24% -0.26%
Next $250,000
2.00%
0.28%
0.22%
0.19% -0.23%
Next $250,000
2.00%
0.25%
0.19%
0.17% -0.21%
Next $250,000
2.00%
0.23%
0.17%
0.13% -0.16%
Next $1,000,000
1.75%
0.19%
0.13%
Next $3,000,000
1.50%
0.10%
0.10%
0.14%
Assets above
$5,000,000
0.08%
0.08%
0.10%
1.25%
0.00% -0.50%
0.00% -0.75%
0.00% -0.75%
Manager Fee
An additional charge of up to 10 basis points (0.10%) is added to your Program Fee if you elect certain tax
management services, ESG or socially responsible screening, or other portfolio customization described in the
SIS. This charge is paid to the investment manager or the “overlay manager” that applies the tax screening to
your investments.
The above Fee Schedules are based on the amount of assets you invest in the Platform and is not dependent
on the amount of trading in the account or the advice given in any particular time period. Transactions in
Contour Wrap Fee accounts are executed for a single wrap fee, which reduces the conflict of interest associated
with executing orders for accounts and earning transaction-based compensation in connection with each order.
You should be aware that lower fees for comparable services could be available from other sources.
If Pershing is the selected Custodian, a $10 mutual fund surcharge applies to purchases and redemptions of
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
certain mutual funds that do not otherwise compensate Pershing for administration and operational accounting
related to fund ownership. Neither Cadaret Grant nor your IAR retain any portion of the mutual fund
surcharge. A list of applicable funds is available upon request.
Changes to Fees
The Advisory Fee component of the Total Fee can only be increased with your written consent. Advisory Fee
changes after the first day of the billing period will be effective on the next billing cycle and will not be prorated.
Your IAR cannot negotiate or change the Program Fee or the Manager Fee. Cadaret Grant can change the
Program Fee schedule at any time by giving prior written notice to you. Following the 30-day notice period, the
new fee schedule will become effective unless you terminate the Contour Agreement. Your continued
acceptance of services will constitute consent to changes in the Total Fee, including an increase in the amount
charged, if any.
Other Fees and Expenses
In addition to the Wrap Fee or Non-Wrap Fee, you will pay individual retirement account (“IRA”) annual
maintenance fees, tax-qualified plan trustee fees, certain custodial fees, and other ancillary charges within a
Contour account, as applicable. You are charged for specific account services, such as account transfer fees,
electronic fund and wire transfer charges, checking fees, paper statements and confirmations, and for other
optional services elected by you on a per event basis. These fees are subject to the pricing schedule set by a
Custodian and Cadaret Grant. Cadaret Grant receives a portion of certain of these fees for accounts in custody
with Pershing, including where Cadaret Grant marks up the fee charged by Pershing, which can be substantial.
Please review Brokerage Practices of this Brochure for additional information.
Our receipt of custodial fees, including where we markup a fee, creates a conflict of interest for Cadaret Grant
because the fees constitute additional revenue to us, and the amount can be substantial. To mitigate this conflict,
we do not share custodial fee revenues with your IAR, and we do not require or incentivize IARs to recommend
advisory programs be custodied with any custodian.
Please refer to the Fee Schedule published in the disclosure section of our website for a detailed schedule of
transaction fees and other brokerage costs (cadaretgrant.com/disclosures/) for a better understanding of where
we receive additional compensation.
You can elect to receive communications and documents from a Custodian, including confirmations and
statements, electronically by enrolling, or registering online, pursuant to Custodian’s instructions for electronic
delivery. Unless you authorize electronic delivery, the Custodian will deliver communications and documents
to you via U.S. mail. If your account is in custody with Pershing, Pershing assesses a paper surcharge.
Interest on all cash account delinquencies (Cash Due Interest) in your account is charged directly to your
account at the then current rate. Transfer agent servicing fees, if any, are passed through to you and can vary
based upon the transfer agent and position.
Brokerage and other transaction costs incurred in Contour FSP, SMA, UMA, and APM Wrap Fee accounts are
included in the Program Fee except as described below under “Additional Fees for Trades Executed at Other
Broker-Dealers” and where Pershing is Custodian, mutual fund surcharges apply to certain funds designated by
Pershing. Brokerage and other transactions costs incurred in Contour APM Non-Wrap Fee accounts are not
included in the Program Fee as described above under “Transaction Charges for Non-Wrap Accounts”.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Additional Fees for Collective Investment Vehicles
For accounts that contain collective investment vehicles (“Collective Investment Vehicles”), such as mutual
funds, closed-end funds, UITs, ETFs, annuities, structured products, or publicly traded real estate investment
trusts (REITs), each Collective Investment Vehicle bears its own internal fees and expenses, such as fund
operating expenses, management fees, redemption fees, regulatory fees, charges assessed by annuity issuers
such as contract charges, contract maintenance charges, transfer charges, optional rider fees, subaccount
management fees, and administrative expenses, short-term trading redemption fees, and other fees imposed
by law. Collective Investment Vehicle fees and expenses are disclosed in the applicable prospectus, statement
of additional information, or product description. None of these fees are shared with Cadaret Grant or your
IAR. This compensation is in addition to the Total Fee resulting in increased costs to you.
Some mutual funds assess redemption fees to investors upon the short-term sale of its funds. Depending on
the mutual fund, this can include sales for rebalancing purposes. Please see the prospectus for the specific
mutual fund for detailed information regarding such fees. In addition, you can incur redemption fees, when the
portfolio manager to an investment strategy determines that it is in your overall interest, in conjunction with
the stated goals of the investment strategy, to divest from certain Collective Investment Vehicles prior to the
expiration of the collective investment vehicle’s minimum holding period. Depending on the length of the
redemption period, the particular investment strategy, and/or market conditions, a portfolio manager may be
able to minimize any redemption fees when, in the portfolio manager’s discretion, it is reasonable to allow you
to remain invested in a Collective Investment Vehicle until expiration of the minimum holding period.
Compensation Related to Mutual Funds and Other Investments
Your IAR, in his/her separate capacity as a Cadaret Grant registered representative (i.e., as a broker) earns
commissions from the sale of mutual funds, variable annuities, ETFs, and other securities. This results in a
conflict of interest because Cadaret Grant and our IARs have an incentive to recommend investment products
based on the compensation received rather than on a client’s needs. You are under no obligation to purchase
investment products through Cadaret Grant or your IAR and you have the option to purchase the products we
recommend through other financial services firms that are not affiliated with us.
After considering your overall needs and objectives along with your preferences, your IAR can recommend that
you convert from a commission-based account to a fee-based advisory account. We maintain policies and
procedures to ensure a conversion from a commission-based account to fee-based advisory account is in your
best interest. Among other things, we employ the following policies:
• When Class A, B, or C shares of mutual funds are transferred into your Contour account, additional
mutual fund purchases within the advisory account will be made at net asset value (NAV) or in adviser
or institutional share classes, which do not include 12b-1 fees. Such purchases will not result in your
payment of a commission in addition to the annual advisory fee.
• Cadaret Grant will attempt to convert Class A, B, and C share mutual fund holdings in an advisory
account to adviser or institutional class shares where available. In the event a tax-free conversion is
unavailable or does not occur, 12b-1 fees received in fee-based accounts will be credited to your
account.
•
If your Contour account is funded with a deposit of one or more open end mutual funds, UITs, or
proceeds from the sale of open-end mutual funds or UITs, where Cadaret Grant was paid a sales charge
in its capacity as a broker-dealer within one year of the initial billing date, you are entitled to a fee offset.
The mutual fund fee offset varies depending on whether the mutual fund was subject to a front-end
or a back-end sales charge. For mutual funds subject to a front-end sales charge, the fee offset is
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
calculated using the number of shares multiplied by the closing price of the security on the day prior
to the initial billing date multiplied by the annual advisory fee. For mutual funds subject to a back-end
sales charge, the fee offset is equal to the amount of the back-end sales charge incurred: (1) upon
liquidation of a mutual fund in the account; or (2) upon liquidation of a mutual fund within 60-days
prior to the date the proceeds are transferred into the account. The unit investment trust fee offset is
calculated in the same manner as the front-end load mutual fund fee offset.
• Your IAR can agree, upon your written request and for your convenience, to hold certain assets in your
Contour account such as previously acquired concentrated positions in a stock or bond that you wish
to hold for an unspecified period of time. Such assets are unmanaged, unmonitored, and are excluded
from billing.
• Your IAR can agree, at your request, to hold certain assets in the Contour account such as previously
acquired concentrated positions in a stock or bond, that you wish to liquidate over a period of time or
hold to maturity. Such assets are being monitored but are excluded from billing.
Mutual funds generally offer multiple share classes available for investment based upon certain eligibility and/or
purchase requirements. For instance, in addition to retail share classes (typically referred to as class A, B, and C
shares), mutual funds can also offer institutional share classes or other share classes that are specifically designed
for purchase by investors who meet certain specified eligibility criteria, including, for example, whether an
account meets certain minimum dollar amount thresholds or is enrolled in an eligible fee-based investment
advisory program. Institutional share classes usually have a lower expense ratio than other share classes. Cadaret
Grant and our IARs have a financial incentive to recommend or select share classes that have higher expense
ratios because such share classes generally result in higher compensation. Cadaret Grant seeks to minimize this
conflict of interest, by providing our IARs with training and guidance on this issue, as well as by conducting
periodic reviews of client holdings in mutual fund investments to ensure the appropriateness of mutual fund
share class selections and whether alternative mutual fund share class selections are available that might be more
appropriate given a client’s particular investment objectives and any other appropriate considerations relevant
to mutual fund share class selection. Regardless of such considerations, clients should not assume that they will
be invested in the share class with the lowest possible expense ratio.
The appropriateness of a particular mutual fund share class selection is dependent upon a number of
considerations, including: the asset-based advisory fee that is charged, whether transaction charges are applied
to the purchase or sale of mutual funds, the overall cost structure of the advisory program, operational
considerations associated with accessing or offering particular share classes (including the presence of selling
agreements with the mutual fund sponsors and Cadaret Grant’s ability to access particular share classes through
the custodian), share class eligibility requirements, and the revenue sharing, distribution fees, shareholder
servicing fees, or other compensation associated with offering a particular class of shares.
Further information regarding fees and charges assessed by a mutual fund is available in the mutual fund
prospectus.
Additional Fees for Trades Executed at Other Broker-Dealers
SMA Managers, Sub-Managers, or Envestnet can elect to execute trades at broker-dealers other than the
Custodian for some or all of their transactions or investment styles. This is frequently referred to as “trading
away” or “step out trades.” Clients who select such managers or participate in the SMA or UMA are subject to
any transaction charges or other charges, including commissions, mark-ups, mark-downs, or other additional
trading costs that can be imposed by the executing broker-dealer in addition to the Program Fee and the other
fees described herein.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Wrap Fee Program versus Non-Wrap Fee Program
We offer asset management services through both wrap fee and non-wrap fee programs.
Wrap Fee Programs
A wrap fee program is defined as an advisory program in which a client pays a single, specified fee for portfolio
management services and trade execution. We receive a portion of the investment advisory fee you pay when
you participate in any of the wrap fee programs we offer. Wrap fee programs are not suitable for all investments
needs and any decision to participate in a wrap fee program should be based on your financial situation,
investment objectives, tolerance for risk, and investment time horizon. The benefit of a wrap fee program
depends, in part, upon the size of an account, the types of securities in the account, and the expected size and
number of transactions likely to be generated. Generally, wrap fee accounts are less expensive for actively traded
accounts. For accounts with little or no trading activity, a wrap fee program may not be suitable because the
wrap fee could be higher than fees in a traditional brokerage or non-wrap fee advisory account where you pay
a fee for advisory services plus a commission or transaction charges foreach transaction in the account. You
should evaluate the total cost for a wrap fee account against the cost of participating in another program or
account.
Non-Wrap Fee Programs
Wrap fee programs differ from other programs in that the fee structure for wrap programs is all-inclusive,
whereas non-wrap fee programs, such as Contour APM Non-Wrap, assess trade execution costs that are in
addition to the investment advisory fees. In Contour APM Non-Wrap, there are two separate types of fees. We
charge an investment advisory fee for our advisory services and another fee (“ticket charge”) is charged for
each transaction (purchase, sale, or exchange) for accounts held at Pershing or Schwab. Cadaret Grant has a
conflict of interest in offering non-wrap accounts custodied through Pershing due to the receipt of additional
transaction-based ticket charge revenue received by us in our capacity as a broker-dealer.
Cadaret Grant maintains policies and procedures to ensure the recommendation of a specific account type is
reasonably believed to be in your best interest. There is no guarantee that the Advisory Services offered will
result in your goals and objectives being met. Nor is there any guarantee of profit or protection from loss. No
assumption can be made that an advisory fee arrangement or portfolio management service of any nature will
provide a better return than other investment vehicles. Advisory programs are not suitable for all investment
needs, and any decision to participate in a wrap fee or non-wrap fee program should be based on your financial
situation, investment objectives, tolerance for risk, and investment time horizon, among other considerations.
You should evaluate the total cost for participating in a particular advisory program in consultation with your
IAR.
General Information Concerning Fees
Fees vary between IARs, and clients can pay more or less than the fees charged by another IAR for similar
services. The advisory fee charged can be more or less than what Cadaret Grant and your IAR might earn from
other programs available in the financial services industry or if the services were purchased separately or on a
commission basis. To this end, clients have the option to purchase investment products that an IAR
recommends through other financial services firms that are not affiliated with Cadaret Grant.
Advisory fees are charged on all mutual fund shares deposited to Contour accounts unless eligible for the fee
offset program described in the section entitled Compensation Related to Mutual Funds and Other Investments
above. Also, to the extent cash used for investment in an account comes from redemptions of your other non-
managed mutual fund investments, you should consider the cost, if any, of the sales charge(s) previously paid
and redemption fees that could be incurred. Such redemption fees would be in addition to the advisory fee on
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
those assets. You should be aware that such redemptions and exchanges between mutual funds within
investment advisory accounts typically have tax consequences in non-retirement accounts, which should be
discussed with an independent tax advisor.
Item 5 – Account Requirements and Types of Clients
Account Requirements
The initial minimum account size for Contour program options is listed below.
Program
Minimum
Advisor as Portfolio Manager Program
$25,000
Fund Strategist Portfolios
As low as $2,000
Separately Managed Accounts
$100,000
Unified Managed Accounts
$100,000
The initial account minimum can, however, be waived at Cadaret Grant’s discretion, considering various factors.
Such factors include, but are not limited to, length of client relationship, or combined values of other
household/family member accounts.
In the SMA program, should the SMA Manager require a higher minimum, the higher minimum will apply. In
the UMA program, the minimum account size for each model style is determined by the Model Provider or
Sub-Manager. For additional information regarding any restrictions imposed by a SMA Manager, Model
Provider, or Sub-Manager, please ask your IAR for their Form ADV Part 2A Brochure.
Types of Clients
Cadaret Grant, through its IARs, offers investment advisory services to individuals, high net worth individuals,
pension and profit-sharing plans, charitable organizations, and corporations or other businesses. Our clients
can have both fee-based advisory accounts and commission-based brokerage accounts. Our IARs can offer
clients advisory services, brokerage services, or both, depending on an IAR’s registrations and qualifications,
and on a client’s preferences and needs.
Item 6 – Portfolio Manager Selection and Evaluation
Cadaret Grant does not utilize the services of any third-party money manager in the APM. In the APM, your
IAR acts as portfolio manager and selects specific investments to implement an asset allocation model
consistent with your investor profile, risk tolerance, and investment objectives. IARs acting as portfolio
managers generally do not have documented performance histories against which to measure. Therefore, IARs
of Cadaret Grant are not subject to the same selection and review process that we use for SMA Managers, Sub-
Managers, Strategists, or Model Providers.
SMA Managers, Sub-Managers, Strategists, and Model Providers
In the SMA and UMA, Envestnet makes available to Cadaret Grant investment managers with whom Envestnet
has entered into agreements to act as SMA Managers or Sub-Managers with respect to the investment of clients’
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Platform Assets in managed securities portfolios, mutual fund portfolios, and exchange-traded fund portfolios.
For certain investment advisors, including Strategists for FSP, Envestnet has entered into a licensing agreement
with the investment adviser whereby Envestnet performs administrative and/or trading duties pursuant to the
direction of the investment adviser. In this scenario, the investment adviser is acting in the role of a “Model
Provider.”
Envestnet has developed a program to collect and report data on investment style and philosophy, past
performance, and personnel of SMA Managers, Sub-Managers, and Model Providers that are designated as
“approved.” Envestnet’s process for selecting, evaluating, and monitoring approved SMA Managers, Sub-
Managers, and Model Providers is more fully described in Envestnet’s Form ADV Brochure. Cadaret Grant
leverages this process in selecting SMA Manages, Sub-Managers, and Model Providers it makes available in
Contour accounts. Envestnet also makes available other managers for which it has not performed due diligence;
Cadaret Grant makes those managers available based on due diligence conducted by the Managed Account
Product Review Committee, a sub-committee of the Atria New Product Committee. This includes review of
investment style and philosophy, past performance, and personnel.
The Managed Account Product Review Committee is responsible for reviewing, selecting, and monitoring SMA
Managers, Sub-Managers, and Model Providers. SMA Managers, Sub- Managers, and Model Providers selected
for participation are also subject to an annual review to determine if there are any material changes or disclosure
events that will impact the quality of the SMA Manager’s, Sub-Manager’s, or Model Provider’s performance of
the services contemplated in the Program. In addition, the Managed Account Product Review Committee
conducts periodic reviews of Envestnet.
Your IAR is responsible for initial SMA Manager and/or Model Provider selection based on the information
you provide at the inception of your account along with your investor profile and results of your RTQ or risk
assessment from an approved financial planning tool. Your IAR is also responsible for monitoring the
appropriateness of the selected SMA Manager(s), Sub- Manager(s), and/or Model Provider(s) in light of any
changes in your financial condition, risk tolerance, and investment objectives reported by you from time to
time.
Performance Calculation
Cadaret Grant has engaged Envestnet to calculate investment performance and to provide reports to clients,
subject to a minimum account value. Neither Cadaret Grant, nor any third party, reviews or verifies the accuracy
of performance or its compliance with any presentation standards.
A custodial statement containing a description of all account activity is provided to you not less than quarterly.
Your IAR reviews overall performance of each account on a periodic basis in order to ensure that transactions
are suitable based on your investment objectives, meet your quality expectations and comply with any
investment restrictions requested by you.
Performance-Based Fees and Side-by-Side Management
Fees based on a share of capital gains or capital appreciation of assets of an advisory client are commonly
referred to as “performance-based fees.” Cadaret Grant does not charge performance- based fees. We also do
not engage in side-by-side management.
Methods of Analysis, Investment Strategies and Risk of Loss
Methods of Analysis and Investment Strategies
Your IAR will incorporate your needs and investment objectives as well as time horizon and risk tolerance
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
when developing and selecting investment strategies. Your IAR is not bound by any specific methods of analysis
or investment strategies for the management of model portfolios in the APM, but rather as previously stated,
your IAR will consider your unique situation and all information gathered at the account inception, your RTQ
or financial plan, as well as changes to your financial picture over time.
The primary sources of information used to conduct these types of analysis are reputable financial publications,
research prepared by others, ratings services, press releases, annual reports, prospectuses, and other filings with
the SEC. The implementation of your IAR’s strategies varies based upon the individual client. Prior to investing,
you should ensure that you understand and agree with the investment strategy used by your IAR.
Each client’s account is managed based on a client’s financial situation, investment objectives, and instructions.
The IAR works with a client to obtain sufficient information to provide individualized investment advice and
is reasonably available to consult with the client on an ongoing basis.
Clients are permitted to impose reasonable restrictions on the management of an account. However, there is a
possibility that by imposing restrictions, you may receive an asset allocation proposal that differs from the
allocation your IAR would otherwise consider appropriate. Clients who do not impose any restrictions are likely
to receive asset allocation proposals that are similar to proposals presented to other clients with similar
investment profiles.
Tax Consequences
Tax consequences are a critical component of any investment strategy. Therefore, depending on the strategy
that you choose to implement, it is possible that any trading activity could result in a taxable event and lower
investment returns. Certain SMA Managers in SMA and Model Providers in UMA and FSP employ tactical
strategies that do not consider taxes, including the avoidance of wash sales, in the management of portfolios.
Since investments could have tax or legal consequences, you should contact your tax professionals and attorneys
to help answer questions about specific situations or needs.
Risk of Loss
Investing in any type of security involves risk of loss that you should be prepared to bear. Cadaret Grant does
not guarantee the performance of an account or any specific level of performance. Market values of the
securities in the account will fluctuate with market conditions. When an account is liquidated, it could be worth
more or less than the amount invested.
There is no guarantee that a client’s investment goals or objectives will be achieved. All securities are subject to
some level of risk which could cause the value of your securities to decrease in value, and in some cases, could
result in a loss of your entire investment The following are some types of risk that could affect the value of
your portfolio:
• Market risk: The risk that changes in the overall market will have an adverse effect on individual
securities, regardless of the issuer’s circumstances.
• Business risk: Whether because of management or adverse circumstances, some businesses will
inevitably fail. This is especially true during economic recessions. For example, a company stock can
become worthless in the event of a bankruptcy, which would result in a loss of principal to
shareholders.
•
Interest rate risk: If the Federal Reserve raises interest rates, the market prices of bonds can be affected.
When interest rates rise, the market prices of bonds typically fall.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
• Regulatory risk: Legislative, regulatory and/or judicial changes that impact businesses can drastically
change entire industries.
•
Industry/company risk: These risks are associated with a particular industry or a specific company
within an industry. For example, oil-drilling companies depend on finding oil and then refining it, which
is a lengthy process before they can generate a profit. They carry a higher risk of fluctuations in
profitability than an electric company, which generates its income from a steady stream of clients who
buy electricity no matter what the economic environment is like.
• Liquidity risk: Certain investments lack liquidity or the ability to access their principal quickly, without
incurring substantial penalties, or the inability to sell the investment until sometime in the future.
•
Inflation risk: When any type of inflation is present, a dollar today will not buy as much as a dollar next
year, because purchasing power is eroding at the rate of inflation.
• Opportunity risk: A client or an IAR can choose a conservative product to invest in, which could cause
the client to miss out on market upswings which potentially could have increased the value of securities
with higher risk. The opposite is also true; market downturns could cause a client to lose a significant
amount of principal invested in higher risk securities, when his or her funds could have been invested
in lower risk options.
• Reinvestment risk: There is a possibility you will be unable to make additional purchases of a security
already in your portfolio at the same rate at which the original purchase was made.
• Currency or exchange rate risk: Foreign securities face the uncertainty that the value of either the
foreign currency or the domestic currency will increase or decrease; either of which will cause the value
of the client’s portfolio to fluctuate.
• Exchange-Traded Funds: ETFs face market trading risks, including the potential lack of an active
market for fund shares, losses from trading in the secondary markets, and disruption in the creation
and redemption process of the ETF. Any of these factors can lead to liquidity risk and/or the fund’s
shares trading at a premium or discount to its “net asset value.”
• Leveraged and inverse ETFs: ETFs that offer leverage or that are designed to perform inversely to the
index or benchmark they track—or both—are growing in number and popularity. While such products
may be useful in some sophisticated trading strategies, they are highly complex financial instruments
that are typically designed to achieve their stated objectives on a daily basis. Due to the effects of
compounding, their performance over longer periods of time can differ significantly from their stated
daily objective. Therefore, inverse and leveraged ETFs that are reset daily typically are unsuitable for
clients who plan to hold them for longer than one trading session, particularly in volatile markets.
•
Interval Funds: Interval funds provide limited liquidity to shareholders by offering to repurchase a
limited number of shares on a periodic basis, but there is no guarantee that a client will be able to sell
all their shares in any particular repurchase offer. The repurchase offer program may be suspended
under certain circumstances.
• Environmental, Social, and Governance (“ESG”) strategies: The implementation of ESG strategies
could cause an account to perform differently compared to accounts that do not use such strategies.
The criteria related to certain ESG strategies can result in an account foregoing opportunities to buy
certain securities when it might otherwise be advantageous to do so, or selling securities to comply with
ESG guidelines when it might be otherwise disadvantageous to do so. In addition, an increased focus
on ESG or sustainability investing in recent years may have led to increased valuations of certain issuers
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
with higher ESG profiles. A reversal of that trend could result in losses with respect to investments in
such issuers. There can be no assurance that an ESG strategy directly correlates with a client’s ESG
goals, and ESG data is not available with respect to all issuers, sectors or industries and is often based
upon estimates, comparisons or projections that may prove to be incorrect. As a result, a client account
with ESG guidelines could nonetheless be invested in issuers that are inconsistent with the client’s
ESG goals.
• Structured Products: A structured product is an unsecured obligation of an issuer with a return,
generally paid at maturity, that is linked to the performance of an underlying asset, such as a security,
basket of securities, an index, a commodity, a debt issuance or a foreign currency. Structured products
are senior unsecured debt of the issuing bank and subject to the credit risk associated with that issuer.
This credit risk exists whether or not the investment held in the account offers principal protection.
Some structured products offer full protection of the principal invested, others offer only partial or no
protection. Investors may be sacrificing a higher yield to obtain the principal guarantee. In addition,
the principal guarantee relates to nominal principal and does not offer inflation protection. An investor
in a structured product never has a claim on the underlying investment. There may be little or no
secondary market for the securities and information regarding independent market pricing for the
securities may be limited. A structured product may contain a call feature that can result in the
investment being redeemed earlier than the stated maturity date. If a structured product is called prior
to maturity, the payment you receive will depend upon the stated terms of the investment. If a
structured product is called, you may not be able to reinvest the proceeds in a similar investment with
similar risk and return characteristics.
• Money Market Mutual Funds: While money market mutual funds seek to preserve a net asset value of
$1.00, during periods of severe market stress, a money market mutual fund could fail to preserve a net
asset value of $1.00 and/or could no longer be a viable business for the fund sponsor, which would
force the sponsor to liquidate. It is possible to lose money by investing in a money market mutual fund.
• Credit risk: The risk that an issuer of a fixed income security may fail to pay interest and/or principal
in a timely manner, or that negative perceptions of the issuer’s ability to make such payments will cause
the price of the security to decline. These risks are greater for securities that are rated below investment
grade (junk bonds), which may be considered speculative and are more volatile than investment grade
securities.
• Options: Holding options for long-term periods could weaken and/or reduce the value of the
underlying stock or create the possibility of a worthless position.
• Global risk: International investing involves a greater degree of risk and increased volatility. Changes
in currency exchange rates and differences in accounting and taxation policies outside the U.S. can raise
or lower returns. Also, some overseas markets are not as politically and economically stable as the
United States and other nations.
• Cybersecurity risk: Cadaret Grant relies on the use and operation of different computer hardware,
software, and online systems. The following risks are inherent in such programs and are enhanced for
online systems: unauthorized access to or corruption, deletion, theft, or misuse of confidential data
relating to Cadaret Grant and its clients; and compromises or failures of systems, networks, devices, or
applications used by Cadaret Grant or its vendors to support its operations.
You should understand and be willing to accept these and other types of risks before choosing to invest in
securities or receive investment advisory services.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Voting Client Securities
You authorize SMA Managers, Sub-Managers, or Envestnet in writing to exercise discretion in voting or
otherwise acting on all matters for which a security holder vote, consent, election, or similar action is solicited
by, or with respect to, issuers of securities beneficially held as part of the Platform Assets in SMA or UMA
accounts. For assets held in APM or FSP accounts, neither Cadaret Grant nor the IAR will exercise any voting
authority and you expressly retain the authority. You can revoke proxy voting authority at any time by providing
written instruction.
You can obtain a copy of our proxy voting policies and procedures upon request, by contacting Cadaret Grant
at the phone number on the front of this Contour Brochure.
Item 7 – Client Information Provided to Portfolio Managers
Information regarding your financial situation, investment objectives, risk tolerance, time horizon, and other
relevant factors as described by you, is gathered prior to opening an account and assists your IAR when
recommending the most appropriate asset allocation model(s) and strategies for you. You should notify your
IAR promptly when changes to your financial situation, objectives, or other personal information occur, so that
your IAR can adjust his or her management of your portfolio, if necessary. You can impose any reasonable
restrictions on the management of the account. Each client is contacted at least annually to determine if any
changes have occurred that could affect the ongoing suitability of the portfolio selected and to determine if any
new restrictions should be imposed on the account.
Item 8 – Client Contact with Portfolio Managers
You are generally free to contact Cadaret Grant and your IAR at any time during normal business hours via
telephone, facsimile, video conference, mail, or email. In-person meetings should be scheduled in advance to
ensure that your IAR is available. Contour SMA Managers, Sub-Managers, Model Providers, and third-party
strategists are not generally available to discuss specific investment issues.
Item 9 – Additional Information
Disciplinary Information
Registered investment advisers are required to disclose all material facts regarding any legal or disciplinary events
that would be material to the client’s evaluation of Cadaret Grant or the integrity of Cadaret Grant’s
management.
Cadaret Grant is a broker-dealer in addition to its activities as a registered investment adviser. In connection
with its broker-dealer business, Cadaret Grant has been the subject of certain regulatory actions, some of which
Cadaret Grant has determined to be immaterial. Others are summarized below:
• On May 28, 2015, Cadaret Grant entered into an AWC with FINRA. FINRA found that, between
January 2011 and December 2014, Cadaret Grant failed to establish and maintain a supervisory system
reasonably designed to supervise variable annuity surrenders and exchanges recommended or
processed by the firm’s registered representatives in violation of NASD Rule 3010 and FINRA Rules
2020, 3110, and 4511. Cadaret Grant consented, without admitting or denying the findings, to a censure
and fine of $75,000, agreed to pay $236,242 in restitution plus interest to certain clients, and agreed to
conduct a review of the adequacy of its written supervisory procedures regarding non-exchange
variable annuity surrenders.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
• On August 1, 2017, the SEC issued an Order Instituting Administrative and Cease- and-Desist
Proceedings, Pursuant to Section 15(B) of the Securities Exchange Act of 1934 and Sections 203(e)
and 203(k) of the Investment Advisers Act of 1940 (the “Advisers Act”), Making Findings, and
Imposing Remedial Sanctions and a Cease- and-Desist Order as to Cadaret Grant. The Order alleges
that (a) between 2011 and 2016, Cadaret Grant purchased, recommended, or held for advisory clients
mutual fund share classes that charged 12b-1 fees instead of lower-cost share classes of the same funds
for which clients were eligible, (b) Cadaret Grant received 12b-1 fees in connection with the
investments, and (c) Cadaret Grant failed to disclose in its Form ADV the conflicts of interest related
to the receipt of 12b-1 fees and its selection of mutual fund share classes that pay such fees. During
the same period Cadaret Grant received marketing support payments from two mutual fund complexes
when the firm investment clients in mutual fund shares classes that charged 12b-1 fees and failed to
disclose this conflict of interest to clients. During the same period, the firm failed to refund unearned
prepaid advisory fees to clients who terminated their accounts. As a result the firm violated Sections
206(2), 206(4), and 207 of the Advisers Act and Rule 206(4)-7. Cadaret Grant agreed, without admitting
or denying the findings, to cease and desist from committing or causing any future violations of
Sections 206(2) and 207 of the Advisers Act, to a censure, to pay a fine of $280,000 and approximately
$2.76 million to compensate investors affected by its conduct, and to notify affected investors of the
entry of the Order.
• On June 12, 2018, Cadaret Grant entered into a Consent Order with the Massachusetts Securities
Division with respect to allegations that between 2010 and 2018 one of the firm’s investment adviser
representatives had a place of business and provided investment advisory services in Massachusetts
when not registered in Massachusetts. Cadaret Grant, without admitting or denying the allegations,
agreed to (a) cease and desist from violating the Massachusetts General Laws Chapter 100A, Section
201(C) and 201(D), (b) register its investment adviser representatives in Massachusetts prior to them
offering services, (c) refund $134,249 in fees charged to clients, and (d) pay a fine of $75,000 and
registration fees of $400.
• On September 11, 2018, the SEC issued an Order Instituting Administrative and Cease-and-Desist
Proceedings, Pursuant to Section 8A of the Securities Act of 1933, Section 15(b) of the Securities
Exchange Act of 1934, and Sections 203(c), 203(f), and 203(k) of the Advisers Act, Making Findings,
and Imposing Remedial Sanctions and a Cease-and-Desist Order as to Cadaret Grant. The Order
alleges that (a) between January 2015 and December 2016, certain Cadaret Grant registered
representatives recommended that customer buy and hold a complex exchange traded note linked to a
crude oil futures index with triple leverage, (b) the representatives did not do a reasonable investigation
or have a reasonable basis for their recommendations, (c) the firm’s supervisory personnel failed to (i)
establish and implement a reasonable supervisory system for determining whether representatives had
a reasonable basis for recommending that investors buy and hold non-traditional exchange traded
products (“ETPs”), (ii) provide training to representatives concerning non-traditional ETPs, (iii)
implement Cadaret Grant’s specific policies and procedures pertaining to representatives’
recommendations to brokerage customers involving non-traditional ETPs, and (iv) devote adequate
resources to supervising representatives. Cadaret Grant also failed to adopt and implement policies and
procedures designed to prevent unsuitable sales of non-traditional ETPs by IARs to investment
advisory clients in light of their investment objectives and financial condition. Cadaret Grant agreed,
without admitting or denying the findings, to cease and desist from committing or causing any future
violations of Sections 206(4) and 206(4)-7 of the Advisers Act, to a censure, to pay disgorgement of
$12,296, prejudgment interest of $898, and a civil penalty of $500,000.
• On September 11, 2018, Cadaret Grant entered into an AWC with FINRA. FINRA found that,
between August 2012 and May 2017, Cadaret Grant failed to establish and maintain a supervisory
system reasonably designed to supervise numerous areas of its business as a result of its failure to
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
devote sufficient resources to supervision of the firm’s personnel. in violation of Section 17(a) of the
Securities Exchange Act, SEC Rule 17a-4, NASD Rule 3010, and FINRA Rules 2020, 2330, 3110, and
4511. Cadaret Grant consented, without admitting or denying the findings, to a censure and fine of
$800,000, and to engage an independent consultant to conduct a review of its policies, systems and
procedures, and training relating to variable annuity sales and exchanges, consolidated reports, and
retention and review of electronic communications.
• On December 17, 2019, Cadaret Grant entered into a Consent Agreement and Order with the
Pennsylvania Department of Banking and Securities with respect to allegations that between January
2015 and September 2019 the firm employed at least one unregistered investment adviser
representative in violation of Section 301(c.1)(1)(ii) of the Pennsylvania Securities Act. Cadaret Grant,
without admitting or denying the allegations, agreed to pay a fine of $90,000.
• On July 1, 2020, Cadaret Grant entered into an AWC with FINRA. FINRA found that, between April
2014 and March 2017, Cadaret Grant failed to reasonably supervise a registered representative who
conducted multiple undisclosed private securities transactions, which were part of a Ponzi scheme that
the registered representative orchestrated that resulted in substantial losses to several clients and that
the firm failed to take reasonable steps to investigate red flags that the registered representative was
involved in private securities transactions in violation of NASD Rule 3010 and FINRA Rules 2020 and
3110. Cadaret Grant consented, without admitting or denying the findings, to a censure and fine of
$200,000.
• On August 12, 2024, the SEC issued an Order Instituting Administrative and Cease-and-Desist
Proceedings pursuant to Section 15(b) of the Securities Exchange Act of 1934 and Sections 203(e) and
203(k) of the Advisers Act, Making Findings, and Imposing Remedial Sanctions and a Cease-and-Desist
Order as to Cadaret Grant. The Order alleges that Cadaret Grant failed to provide full and fair
disclosure regarding conflicts of interest associated with its receipt of: (1) revenue sharing payments
from Cadaret Grant’s unaffiliated clearing broker as a result of advisory clients’ investments in certain
no-transaction fee (“NTF”) mutual fund share classes from at least January 2017 until January 2020; (2)
revenue sharing payments from its unaffiliated clearing broker as a result of sweeping cash into certain
money market mutual funds from at least January 2017 until March 2022; and (3) markups on the
unaffiliated clearing broker’s fees for certain advisory clients’ transaction fees (“transaction fee
markups”) from at least January 2017 until June 2020. The Order further alleges that Cadaret Grant
breached its duty to seek best execution by causing certain advisory clients to invest in certain share
classes of NTF mutual funds when share classes of the same funds were available to the clients that
presented a more favorable value for these clients under the particular circumstances in place at the
time of the transactions, and that Cadaret Grant breached its duty of care by failing to undertake an
analysis to determine whether the particular mutual fund shares class and money market fund it
recommended was in the best interests of its advisory clients. Finally, the Order alleges that Cadaret
Grant failed to adopt and implement written compliance policies and procedures reasonably designed
to prevent violations of the Advisers Act and the rules thereunder in connection with its practices
regarding mutual fund share class and money market fund selection, transaction fee markups, and
seeking best execution. Without admitting or denying the findings, Cadaret Grant agreed to cease and
desist from committing or causing any future violations of Sections 206(2) and 206(4) of the Advisers
Act and Rule 206(4)-7 promulgated thereunder, to a censure, to pay approximately $4.2 million and
interest to compensate investors affected by its conduct, a civil penalty of $1 million, and to a number
of undertakings, including to notify affected investors of the entry of the Order.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Cadaret Grant, as a broker-dealer, is regulated by each of the 50 states and has been subject to orders related to
the violation of certain state laws and regulations in connection with its brokerage activities. For more
information about these state events and other disciplinary and legal events involving Cadaret Grant and its
IARs, clients should refer to Investment Adviser Public Disclosure at www.adviserinfo.sec.gov or FINRA
BrokerCheck® at https://brokercheck.finra.org.
Other Financial Industry Activities and Affiliations
Cadaret Grant is registered as a broker-dealer and as an investment adviser with the SEC. Cadaret Grant is a
member of FINRA and SIPC. Cadaret Grant is also licensed as an insurance agency in all states.
Cadaret Grant is an indirect wholly owned subsidiary of Atria Wealth Solutions, Inc. (Atria). Cadaret Grant has
the following affiliates.
CFS Insurance and Technology Services, LLC
Insurance Agency
CUSO Financial Services, LP
Broker Dealer & Registered Investment Adviser
Fiduciary Trust Company of New Hampshire
Banking or Thrift Institution
Grove Point Advisors, LLC
Grove Point Investments, LLC
Registered Investment Adviser
Broker Dealer & Insurance Agency
LPL Enterprise, LLC
Broker Dealer, Registered Investment Adviser, and Insurance Agency
LPL Financial LLC
Broker Dealer, Registered Investment Adviser, and Insurance Agency
LPL Insurance Associates, Inc.
Insurance Agency
NEXT Financial Group, Inc.
Broker Dealer, Registered Investment Adviser and Insurance Agency
NEXT Financial Insurance Services Company (NFISCO)
Insurance Agency
SCF Investment Advisors, Inc.
Registered Investment Adviser
SCF Securities, Inc.
Broker Dealer & Insurance Agency
Sorrento Pacific Financial, LLC
Broker Dealer, Registered Investment Adviser, and Insurance Agency
The Private Trust Company, N.A.
Banking or Thrift Institution
Western International Securities, Inc.
Broker Dealer, Registered Investment Adviser, and Insurance Agency
Conflicts of Interest as a Broker-Dealer and Insurance Agency
Cadaret Grant is dually registered as both a broker-dealer and as a registered investment adviser and is also a
licensed insurance agency. Most of our IARs are registered with us as a registered representative, which allows
them to perform brokerage services for you by executing securities transactions. Each IAR is an independent
contractor with Cadaret Grant. In their capacity as registered representatives, IARs offer securities and receive
commissions as a result of such transactions. There is a conflict of interest when an IAR is able to choose
between offering a client fee-based programs and services (as is typical of an advisory relationship) and/or
commission-based products and services (as is typical of a brokerage relationship). There is a difference in how
Cadaret Grant and your IAR are compensated for advisory accounts and brokerage accounts or insurance
products. While a client pays a fee to their IAR on an advisory account based on the value of account assets
and not the number of transactions, in their capacities as registered representatives, an IAR can offer securities
and receive a commission, markup, or markdown on each transaction. To mitigate this conflict, we review our
client accounts and transactions to ensure that we have a reasonable basis to believe the recommended services
and transactions are consistent with a client’s stated goals, objectives, preferences, and needs.
Cadaret Grant’s registration as a broker-dealer is material to our advisory business because advisory accounts
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
are custodied with Pershing, a third-party custodian, where we act in our capacity as an introducing broker-
dealer. This results in additional forms of compensation to Cadaret Grant which are discussed in this brochure.
See Brokerage Practices – Pershing Clearing Relationship, Indirect Compensation and Revenue Sharing.
Many of our IARs are also licensed insurance agents appointed with various insurance companies. An IAR can
be contracted and appointed as an independent insurance agent or as an insurance agent with Cadaret Grant.
Acting in the capacity of an insurance agent, IARs can sell annuities and insurance products to advisory clients
and earn commissions for these transactions.
Clients are under no obligation to purchase products or services recommended by an IAR or through an IAR
or otherwise through Cadaret Grant or its affiliates. Clients are free to implement recommendations through
any broker-dealer or advisory firm. If you request that an IAR recommend a broker-dealer, the IAR will
recommend Cadaret Grant; however, you are under no obligation to effect transactions through us.
An IAR’s Outside Business Activities
Our IARs are independent contractors and can engage in certain approved outside business activities other than
providing brokerage and advisory services through Cadaret Grant, and in certain cases, an IAR receives more
compensation, benefits, and non-cash compensation through an outside business activity than through Cadaret
Grant. This creates a conflict of interest because IARs have an incentive to spend more time and attention on
other ventures than on managing your account. Some of our IARs are accountants, real estate agents, insurance
agents, tax preparers, or lawyers, and some refer clients to other service providers and receive referral fees. As
an example, an IAR could provide advisory or financial planning services through an unaffiliated investment
advisory firm, sell insurance through a separate business, or provide third-party administration to retirement
plans through a separate firm. If an IAR provides investment services to a retirement plan as our representative
and also provides administration services to the plan through a separate firm, this typically means the IAR is
compensated from the plan for the two services. In addition, an IAR can sell insurance through an insurance
agency not affiliated with Cadaret Grant. In those circumstances, the IAR is subject to the policies and
procedures of the third-party insurance agency related to the sale of insurance products and would have
different conflicts of interest than when acting on behalf of Cadaret Grant. When an IAR receives
compensation, benefits, and non-cash compensation through the third-party insurance agency, the IAR has an
incentive to recommend you purchase insurance products away from Cadaret Grant. If you contract with an
IAR for services separate or away from Cadaret Grant, you should discuss with them any questions you have
about the compensation they receive from the engagement. Additional information about a IAR’s outside
business activities is available on FINRA's website at brokercheck.finra.org.
Conflicts of Interest with Independent Registered Investment Advisers
In addition to or in lieu of their capacity as an IAR of Cadaret Grant, certain IARs own their own registered
independent investment advisory firms (an “Independent RIA”). An IAR of an Independent RIA can have
three different but concurrent roles:
• As a registered representative with Cadaret Grant who receives commissions for effecting securities
transactions;
• As an IAR of Cadaret Grant who receives a fee for rendering advisory services on behalf of Cadaret
Grant; and/or
• As an IAR of an Independent RIA who offers services outside of Cadaret Grant.
You should be aware that the receipt of additional compensation while acting in concurrent roles creates a
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
conflict of interest and impairs the objectivity of these IARs when making advisory recommendations.
If your IAR is associated with an Independent RIA, this will be disclosed on your IAR’s Part 2B of Form ADV.
Depending on the terms negotiated, your IAR can retain a higher percentage of the advisory fee for services
provided through an Independent RIA than would be retained when services are provided through Cadaret
Grant. You should ask your IAR if purchasing services through an Independent RIA would result in increased
costs to you. You are not obligated to purchase recommended investment products from our IARs or their
Independent RIAs.
Conflicts of Interest as an Insurance Agency
Cadaret Grant is licensed as an insurance agency. An IAR can offer insurance through Cadaret Grant or through
an independent insurance agency. When acting in the capacity of an insurance agent, IARs can effect
transactions in insurance products for clients and earn commissions for these activities.
The fees paid to Cadaret Grant for advisory services are separate and distinct from the insurance commissions
earned by Cadaret Grant and/or its insurance agents. Clients are under no obligation to use Cadaret Grant
and/or its insurance agents for insurance services and can use the insurance agency and agent of their choosing.
Code of Ethics, Participation or Interest in Client Transactions, and Personal
Trading
Cadaret Grant has adopted a Code of Ethics (“Code”) which sets forth standards of business conduct, which
all associated persons of Cadaret Grant are required to follow. The Code also describes certain reporting
requirements with which covered persons must comply. The Code includes provisions relating to the
confidentiality of client information, insider trading, gifts and entertainment, and personal securities trading,
among other things.
Cadaret Grant’s clients or prospective clients can request a copy of Cadaret Grant’s Code by contacting us using
the contact information on the cover page of this Brochure.
IARs will often invest in the same securities recommended to clients. Generally, these securities are shares of
open-end mutual funds or stocks and bonds actively traded on a national securities exchange or market where
the time and size of the transactions will not affect purchases or sales for clients. They can also make purchases
for their own accounts at or about the same time as the purchases/sales are made in client accounts. Orders
for clients and orders for IARs’ own accounts are sometimes aggregated in “block trades” or aggregated orders.
Aggregated orders can achieve better execution for all participating accounts and those advantages will be fairly
allocated among participating accounts.
IARs can hold positions in securities held or recommended to clients but are not allowed to front- run or
otherwise benefit from these positions. Internal procedures have been instituted to ensure that the client is
treated fairly in execution of all trades.
To avoid conflicts of interest, our IARs are prohibited from buying or selling securities for their personal
accounts where their decision is substantially derived, in whole or in part, by reason of their employment unless
the information is also available to the investing public on reasonable inquiry. No IAR may place their own
interests over those of the client. Further, our IARs must comply with all applicable federal and state regulations
governing registered investment advisers.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Brokerage Practices
Cadaret Grant is registered as a broker-dealer with the SEC and provides various services as an introducing
broker-dealer for which it is compensated by a commission or ticket charge. Cadaret Grant has no brokerage
soft dollar arrangements and receives no benefits or research in exchange for executions.
Contour accounts are custodied with an unaffiliated custodian designated by a client. Custodial options in
Contour include, but are not limited to, Pershing and Schwab. When Pershing is selected to execute transactions
and custody account assets in connection with Contour, Cadaret Grant acts as an introducing broker. When a
Contour Non-Wrap Fee account is custodied at Pershing, clients can incur higher transaction costs in the form
of commissions or ticket charges than if their accounts were held elsewhere. When using a Non-Wrap Fee
option, the brokerage commissions and/or transaction fees charged by Cadaret Grant, Pershing, and Schwab
are exclusive of (and in addition to) Cadaret Grant’s advisory fee.
In the AMP and FSP, you authorize us to direct all transactions through a designated broker-dealer. You cannot
request that your orders be executed through another broker-dealer. When directing execution of all
transactions through a particular broker-dealer, there is no assurance that most favorable execution will be
obtained, which could cost you more money. Not all advisers require clients to direct transaction executions to
specified broker-dealers, as we do. This creates a conflict of interest for accounts custodied at Pershing because
of the economic benefits Cadaret Grant receives. We periodically review the execution quality of available
broker-dealers to confirm that the quality we receive is comparable to what could be obtained through other
qualified broker-dealers.
For accounts custodied at Pershing, Cadaret Grant relies in part on review of execution quality, the details of
which are made available to us for our review. In addition, to assist in evaluating the quality of equity executions,
we engage the services of a third-party consultant who monitors Pershing’s equity executions for quality and
helps us identify transactions that are eligible for price improvement.
In SMA and UMA, SMA Managers, Sub-Managers, or Envestnet, as Overlay Manager, can elect to execute
trades at broker-dealers other than the Custodian for some or all of their transactions or investment styles. This
is referred to as “trading away” or “step out trades.” Clients who select such managers in the SMA or UMA are
subject to transaction charges or other charges, including commissions, mark-ups, mark-downs, or other
additional trading costs that can be imposed by the executing broker-dealer. You should refer to the applicable
SMA Manager’s, Sub-Manager’s, or Envestnet’s Form ADV Part 2A for additional information.
Contour accounts are managed based on model portfolio strategies. One or more clients can have the same
model portfolio, based on their investment objective and risk profile. We typically aggregate orders into block
trades when models are rebalanced or if one or more securities are added or removed from a model.
Transactions can, however, be executed independent of transactions for other clients. An IAR must reasonably
believe that a block order is consistent with our duty to seek best execution and will benefit each client
participating in the aggregated order.
When we aggregate orders, we do so in a manner reasonably designed to ensure that no participating client
obtains a more favorable execution price than another. Transactions are typically aggregated pro rata to the
participating client accounts in proportion to the size of the order placed for each account. If we are unable to
fully execute an aggregated order and we determine that it would be impractical to allocate a smaller number of
securities among the participating accounts on a pro rata basis, we will seek to allocate the securities in a manner
that does not disadvantage particular client accounts.
Cadaret Grant is not affiliated with Pershing or Schwab. For accounts under the Non-Wrap Fee option, the
commissions and/or transaction fees charged by Cadaret Grant, Pershing, and Schwab can be higher or lower
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
than those charged by other broker-dealers. However, a client can pay a commission that is higher than another
qualified broker-dealer might charge to effect the same transaction where Cadaret Grant determines, in good
faith, that the commission is reasonable in relation to the value of the brokerage and services received. In
seeking best execution, the determinative factor is not the lowest possible cost, but whether the transaction
represents the best qualitative execution, taking into consideration the full range of a broker-dealer’s services,
including the broker’s expertise, the price at which the trade executed relative to other trades in the security,
the value of research provided, execution capability, commission rates, and the broker’s integrity and
responsiveness. Consistent with the foregoing, while Cadaret Grant and/or our IARs seek competitive rates,
you should not expect that we will necessarily obtain the lowest possible commission rates for client
transactions. Also, and as noted above, we periodically review the execution quality of available broker-dealers
to confirm that the quality we receive is comparable to what could be obtained through other qualified broker-
dealers.
Schwab and Pershing provide Cadaret Grant and our IARs with access to institutional trading, portfolio
management, brokerage and custodial services, research, and access to mutual funds and other investments that
are otherwise generally available only for institutional investors or would require a higher minimum initial
investment.
Schwab and Pershing do not charge a separate fee for custody of Cadaret Grant’s client accounts that they
maintain but are compensated by the account holders through commissions or other transaction-related fees
for security trades that are executed through them or settle into their accounts and for various account fees.
Cadaret Grant receives other products and services from Schwab and Pershing that benefits Cadaret Grant, but
not client accounts. Some of these other products and services assist Cadaret Grant in managing and
administering client accounts. These include software and other technology that provide access to client account
data (such as trade confirmations and account statements), facilitate trade execution (and allocation of
aggregated trade orders for multiple client accounts), facilitate payment of Cadaret Grant’s fees from client’s
accounts, and assist with back-office functions, record keeping and client reporting. These services can be used
to service all or a substantial number of client accounts, including accounts not maintained at Pershing or
Schwab.
Cadaret Grant also receives services from Schwab and Pershing that are intended to help Cadaret Grant manage
and further develop its business. These services include information technology, regulatory compliance, and
marketing. In addition, Schwab and Pershing make available, arrange and/or pay for these types of services
furnished to Cadaret Grant by independent third parties. Schwab and Pershing can discount or waive fees they
would otherwise charge for some of these services or pay all or a part of the fees of the third party providing
the services to Cadaret Grant.
Cadaret Grant or our IARs can make recommendations that clients maintain their assets in accounts at Schwab
or Pershing. These recommendations can be based in part on the benefits to a client, such as the availability of
some of the foregoing products and services and not solely on the nature, cost, or quality of custody and
brokerage services provided by the custodian, which creates a conflict of interest.
Clients of Cadaret Grant should be aware that if they direct Cadaret Grant or our IARs to use a particular
broker, it can limit Cadaret Grant’s or our IARs’ ability to achieve best execution, negotiate commissions with
other brokers on behalf of the client, or limit the client's participation in block trading.
Pershing Clearing Relationship
Pershing is the clearing firm for Cadaret Grant’s brokerage business and is also a custodial option for Contour
accounts. Pershing offers their broker-dealer clients substantial financial strength and stability, economies of
scale, and reliable, state-of-the-art technology. As part of this business relationship, Cadaret Grant pays Pershing
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
various execution and clearing charges and fees in connection with Pershing maintaining custody and effecting
the purchase and sale of securities for Cadaret Grant’s clients. Pershing’s execution and clearing charges are
included in the commissions and transaction charges or fees that Cadaret Grant charges its clients. Pershing
pays Cadaret Grant the portion of commissions and transactions fees that exceed its execution and clearing
charges. Cadaret Grant does not share any of this revenue received from Pershing for investment advisory
accounts with our IARs.
Pershing charges Cadaret Grant for certain account services for accounts custodied with Pershing (including
advisory accounts), including clearing and executing transactions, outgoing transfers, wired funds, direct
registration of securities, paper statements and confirms, margin extensions, ticket charges, and IRA custodial
maintenance and termination. Cadaret Grant sets its own price for certain services. Cadaret Grant charges
clients more for certain services than it pays Pershing, which is sometimes called a “markup,” and the markups
vary by product and the type of service and can be substantial. Cadaret Grant keeps the difference between the
fees and charges our clients pay and the amount paid to Pershing to cover the costs associated with processing
transactions and providing other services.
The economic arrangements between Cadaret Grant and Pershing (including the fees charged by Pershing) can
be renegotiated and change from time to time, including in circumstances where Cadaret Grant realizes net
savings or increased profits from the changed arrangements and Cadaret Grant does pass on any net savings or
increased profits in the form of reduced fees and charges to clients. This practice creates a conflict of interest
for us since we have a financial incentive to recommend Pershing since we receive substantial compensation
for the services we provide. IARs do not receive a portion of these fees.
Our clearing relationship with Pershing provides us with certain economic benefits and compensation by using
ourselves as the broker-dealer for our advisory programs that would not be received if we used an unaffiliated,
third-party broker-dealer for our advisory programs. For example, we add a markup to the transaction costs in
the Non-Wrap Fee Contour APM program and certain other brokerage-related account charges and fees that
are assessed to all client accounts at Pershing. The charges and fees that are marked up are set forth in our
Account Fee Schedule on our website under Disclosures (cadaretgrant.com/disclosures/). The additional
compensation we receive creates a significant conflict of interest with our clients because we have a substantial
economic incentive to use Pershing as the clearing firm for trade execution and custody over other firms that
do not share compensation with us. The revenue and compensation we receive from Pershing is related to both
advisory and brokerage accounts custodied on the Pershing platform. Our IARs do not receive any portion of
this compensation.
For assets in the Contour program, Cadaret Grant pays a recurring fee to Pershing based on a percentage of
the aggregate assets invested by advisory clients, excluding certain investments, such as alternative investments.
When the assets in the Contour program custodied at Pershing increase, the fee we pay decreases. This creates
a conflict of interest for Cadaret Grant as we have an incentive to recommend advisory clients use Pershing as
a custodian over other custodians and to recommend that you increase the amount you have invested in your
Contour account.
Pershing pays shares with Cadaret Grant the following items:
• For accounts in custody with Pershing with cash balances automatically transferred (swept) into the
Dreyfus Insured Deposits P - Tiered Rate Product (DIDP) program, a portion of the fees paid by each
participating bank receiving swept funds (each a “Program Bank”) equal to a percentage of the average
daily deposits at the Program Banks. The combined fee paid to Cadaret Grant, Pershing, and a third-
party administrator will not exceed 4% per year on the average daily balances held in all deposit
accounts taken in the aggregate. Cadaret Grant sets the amount of the fee it charges and retains, which
may exceed the amount of interest paid to clients;
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
• For IRA accounts in custody with Pershing with cash balances automatically transferred (swept) into
the Dreyfus Insured Deposits LF – Level Fee Product (DILF), a level monthly fee for each IRA that
participates in the DILF program. The amount of this fee is determined based on a fee schedule
indexed to the Federal Fund Target Rate published by the Federal Reserve System as detailed in the
DILF Disclosure Statement and Terms and Conditions for the Level Fee Product located at
cadaretgrant.com/disclosures. The per account monthly fee will be no less than $0.58 and no more
than $20.59. It is generally anticipated that the fee Cadaret Grant charges will be offset by the total
amounts paid to Cadaret Grant by Program Banks. If Cadaret Grant does not receive sufficient
payments each month from Program Banks, Cadaret Grant reserves the right to debit each IRA
account for the amount of any shortfall;
• For brokerage accounts in custody with Pershing that have not been converted to either the Dreyfus
Insured Deposits P - Tiered Rate Product (DIDP) or Dreyfus Insured Deposits LF – Level Fee Product
(DILF) programs, a portion of the revenue Pershing receives from uninvested client cash balances in
such accounts automatically swept into money market funds and FDIC insured bank deposit products
of up to 0.60% of the value of cash balances. These payments vary based on the bank deposit account
or money market fund a client has selected;
• Transition assistance in the form of (a) reimbursement of IRA termination fees of up to $165 per
account for a retirement account transferred to Pershing and up to $125 per retail account for retail
accounts transferred to Pershing, or (b) a payment on the value of the assets transitioned, or (c) some
combination of fee reimbursements and a payment on the value of assets transitioned;
• A growth assistance credit to support, service, and grow brokerage assets on the Pershing platform;
• A portion of certain brokerage account services and custodial fees charged to client accounts that
exceeds the amount that we are required to pay Pershing for such services, including account transfer
fees, IRA custodial and termination fees, paper confirm and statement fees, inactive (custodial) account
fees, retirement account maintenance fees, and margin interest and/or fees;
• A portion of shareholder servicing fees from certain mutual fund sponsors as part of their FundVest
Focus® no transaction fee mutual fund program (FundVest) as described below; and
• A rebate of a portion of clearing charges paid for equity and ETF transactions if the volume of
transactions exceeds a certain number each month.
If Cadaret Grant or Pershing terminate their clearing agreement, Cadaret Grant is subject to a termination fee
of $1,000,000. In addition, if the clearing agreement terminates or more than 30% of Cadaret Grant’s client
assets move to a custodial platform outside of Pershing prior to June 1, 2026, Cadaret Grant must repay the
transition assistance and growth assistance payments received in the year the agreement terminates. This
arrangement creates an incentive for Cadaret Grant to require you to use Pershing for brokerage services, over
another third-party broker. Pershing may request a review and renegotiation of its charges if the revenue that
Pershing receives from Cadaret Grant declines by ten percent or more in any six-month period.
In the FundVest program, Cadaret Grant is eligible to receive through a contractual agreement with Pershing,
100% of 12b-1 fees paid by participating mutual funds, and for participating mutual funds that do not pay 12b-
1 fees, up to 57.5% of FundVest service fees paid by participating mutual funds to Pershing for FundVest assets
over a threshold amount that are held in the aggregate in clients’ brokerage and advisory accounts. Our receipt
of a portion of the FundVest service fees creates a conflict of interest because we have an incentive to invest
your assets or to recommend that you purchase or hold these mutual funds that pay fees to Pershing that is
shared with Cadaret Grant over other mutual funds that do not pay these fees. To mitigate this conflict, we do
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
not share these fees with IARs, and we do not require or incentivize our IARs to recommend FundVest mutual
funds. We credit all 12b-1 fees we receive to clients’ advisory accounts.
Most FundVest mutual funds have higher internal expenses than mutual funds that are not in the FundVest
program, and the share classes of funds in the program have higher internal expenses than share classes not in
the program. The higher internal expenses will reduce the long-term performance of an account when compared
to an account that holds lower-cost share classes of the same fund. Clients should ask whether lower-cost
mutual funds are available and/or appropriate for their account considering their expected investment holding
periods, amounts invested, and anticipated trading frequency. FundVest funds held less than six months are
also subject to a short-term redemption fee of $50 which will be charged to your account. Further information
regarding mutual fund fees is available in the applicable mutual fund prospectus. For a list of funds participating
in the FundVest program, please contact us using the contact information provided on the cover of this
Brochure. Pershing, in its sole discretion, may add or remove mutual funds from the FundVest program or may
terminate the FundVest program without prior notice.
Margin Accounts
Pershing offers margin accounts for our clients where you may borrow funds for the purpose of purchasing
additional securities. You may also use a margin account to borrow money to pay for fees associated with your
account or to withdraw funds. If you decide to open a margin account, please carefully consider that: (i) if you
do not have available cash in your account and use margin, you are borrowing money to purchase securities,
pay for fees associated with your account, or withdraw funds; and (ii) you are using the investments that you
own in the account as collateral. Please carefully review the margin disclosure document for additional risks
involved in opening a margin account.
Money borrowed in a margin account is charged an interest rate that is subject to change over time. This interest
payment is in addition to other fees associated with your account.
Pershing and Cadaret Grant charge interest on margin loans to clients. Under its agreement with Pershing,
Cadaret Grant sets the interest rate for margin loans in a range from 0.25% to 2.75% above the Pershing base
lending rate depending on the amount of the margin advance. Cadaret Grant receives compensation in an
amount by which the interest rate exceeds the Pershing base lending rate less 1%. Cadaret Grant has a conflict
of interest in recommending to you a margin loan because Cadaret Grant (in its capacity as a broker-dealer)
receives a markup on the interest charged on the loan. Your IAR is not compensated on margin loan balances
and therefore does not have a conflict of interest in recommending the use of margin. Consequently, Cadaret
Grant maintains policies and procedures to ensure recommendations made to you are in your best interest and
in conjunction with the lack of compensation to your IAR, believe this mitigates the conflict of interest that
Cadaret Grant has in recommending margin loans.
LoanAdvance Program
If your account is custodied with Pershing, you can participate in Pershing’s LoanAdvance™ program which
enables clients to collateralize certain investment accounts to obtain secured loans. In LoanAdvance, clients are
charged a rate of interest that is a floating rate not more than 3 percentage points above the Fed Funds Target
Rate as published in The Wall Street Journal, plus 200 basis points. We receive compensation in an amount by
which the interest rate is marked up over this rate and share it with your IAR. Cadaret Grant and our IARs
have an incentive to recommend that Clients borrow money rather than liquidating some of their account assets
so that Cadaret Grant and our IARs can continue to receive advisory fees on those assets. This results in
additional compensation in connection with a client’s advisory account. Trading is permissible in the advisory
account that is pledged for the loan; however, the collateral must meet Pershing’s LoanAdvance maintenance
requirement to support the loan.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Securities Lending
You are able to enroll in Pershing’s Fully Paid Securities Lending program, which enables qualified clients to
lend fully paid-for securities to Pershing. Pershing earns revenue from lending these securities and a portion of
that revenue is shared with you, Cadaret Grant, and your IAR. Cadaret Grant and your IAR share in 5% of the
revenue received. The receipt of this extra compensation creates a conflict in certain advisory programs in which
your IAR acts as the portfolio manager. The conflict surrounds whether this extra compensation would cause
your IAR to hold a security in your account that would have otherwise been liquidated but not for receipt of
additional compensation. This conflict is mitigated by our requirement that investment decisions made by your
IAR must be in your best interest, as well as the fact that if an account holds these positions, your IAR’s
compensation will increase nominally, but the security will also generate income for your account. Not all
accounts or clients qualify for this program.
IARs who are registered representatives of Cadaret Grant also receive commissions from Cadaret Grant in their
separate capacity as registered representatives of Cadaret Grant in connection with the sale of financial products
they recommend. Receiving such commissions creates a conflict of interest for the IAR and our firm.
Accordingly, we monitor and supervise these activities to ensure recommendations of financial products are
suitable based upon your financial needs, investment objectives, and risk tolerance.
Cash Sweep Options
Cadaret Grant, through our clearing firm, Pershing, offers a cash sweep program to automatically move (sweep)
uninvested cash balances held in brokerage accounts into either an interest-bearing Federal Deposit Insurance
Corporation (“FDIC”) insured deposit account through a Dreyfus Insured Deposits Program or a money
market mutual fund, depending on the account type. Generally, each account is eligible for a single sweep
product chosen specifically for that account type. Retail individual brokerage accounts (including investment
advisory accounts), and business advisory or brokerage accounts are swept to the Dreyfus Insured Deposits P
– Tiered Rate Product (“DIDP”), individual retirement accounts (IRAs) other than SIMPLE IRAs (SEPs) are
swept to the Dreyfus Insured Deposits LF – Level Fee Product (“DILF”), and all ERISA Title I accounts are
swept to the Dreyfus Government Cash Management – Investor Shares (“DGVXX”) money market mutual
fund.
For deposit accounts in the DIDP program, Pershing receives a fee from each participating bank receiving
swept funds (each a “Program Bank”) equal to a percentage of the average daily deposits at the Program Banks.
Pershing shares the fee with Cadaret Grant and a third-party administrator. The combined fee paid to Cadaret
Grant, Pershing, and the administrator will not exceed 4% per year on the average daily balances held in all
deposit accounts taken in the aggregate. Cadaret Grant receives a substantial portion of this fee but not more
than 3.30% per year.
For IRAs, Cadaret Grant receives a level monthly fee for each IRA that participates in the DILF program. The
amount of this fee is determined based on a fee schedule indexed to the Federal Fund Target Rate published
by the Federal Reserve System. The per account monthly fee will be no less than $0.58 and no more than
$20.59. It is generally anticipated that the fee Cadaret Grant charges will be offset by the total amounts paid to
us by the Program Banks. If Cadaret Grant does not receive sufficient payments each month from the Program
Banks, Cadaret Grant reserves the right to debit your IRA account for the amount of any shortfall.
Your deposits at each Program Bank are limited to $246,500, or $493,000 for a joint account (98.5% of the
deposit insurance limit). Once this amount is reached at a Program Bank, additional amounts are deposited in
subsequent Program Banks in amounts not to exceed $246,500 at each Program Bank. Any amounts deposited
above the $2.490 million program maximum ($4.980 million for joint accounts) will be placed in shares of the
DGVXX money market mutual fund and will not be covered by FDIC insurance.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
For additional information on the DIDP and DILF program, please see the disclosure statement and terms and
conditions booklets available on cadaretgrant.com/disclosures.
The DGVXX money market mutual fund is eligible for protection by the Securities Investor Protection
Corporation (“SIPC”). SIPC does not protect against the rise and fall in the value of investments.
You may elect to turn off (i.e., opt out of) the automatic sweep feature by contacting your IAR. If you opt out,
any cash balances in your account will remain as free credit balances and will not earn interest or be eligible for
FDIC insurance but will remain eligible for SIPC coverage if maintained for the purpose of purchasing
securities.
Depending on interest rates and other market factors, the yields on the DIDP and DILF will be higher or lower
than the aggregate fees received by Cadaret Grant for your participation in the sweep programs. When yields
are lower, this results in a negative overall return with respect to cash balances in a sweep program. Interest
rates applicable to DIDP or DILF are often lower than the interest rates available if you make deposits directly
with a bank or other depository institution outside of Cadaret Grant’s brokerage platform or invest in a money
market mutual fund or other cash equivalent.
Cadaret Grant receives more revenue when cash is swept into DIDP or DILF than if your cash was invested
in other products, including money market mutual funds. Therefore, Cadaret Grant has an incentive to place
and maintain your assets in the DIDP and DILF programs to earn more income, which creates a conflict of
interest. A further conflict of interest arises as a result of the financial incentive for Cadaret Grant to recommend
and offer the DIDP due to Cadaret Grant’s control of certain functions. Cadaret Grant sets the interest rate
tiers and the amount of the fee it receives for the DIDP, which generates additional compensation for Cadaret
Grant. The compensation Cadaret Grant receives for DIDP and DILF is in addition to any remuneration
Cadaret Grant and your IAR receive in connection with other transactions executed within your account for
which advisory fees or other charges apply. We mitigate these types of conflicts by ensuring that your IAR does
not receive any compensation from these sweep payments, and by maintaining policies and procedures to
ensure that any recommendations made to you are in your best interest. You should compare the terms, interest
rates, required minimum amounts, and other features of the sweep program with other types of accounts and
investments for cash. The sweep products have limited purpose and are not meant as a long-term investment
or a cash alternative.
The DIDP and DILF programs are available only to clients of broker-dealers such as Cadaret Grant that clear
through Pershing. Pershing is a wholly owned indirect subsidiary of The Bank of New York Mellon Corporation
and is affiliated with (a) The Bank of New York Mellon, a NY state-chartered bank, and BNY Mellon, National
Association, a national banking association, both of which participate as Program Banks in DIDP and DILF,
(b) Dreyfus Cash Solutions, a division of BNY Mellon Securities Corporation, which is a service provider for
DIDP and DILF, and (c) Dreyfus, a division of BNY Mellon Investment Adviser, Inc. and the investment
manager of the Dreyfus money market mutual fund made available to accounts not eligible for DIDP or DILF.
Schwab Custodial Relationship
Cadaret Grant may recommend that clients establish brokerage accounts with the Schwab Advisor Services
division of Charles Schwab & Co., Inc. (Schwab), a registered broker-dealer, member SIPC, to maintain custody
of clients’ assets and to effect trades for their accounts. The final decision to custody assets with Schwab is at
the discretion of the Advisor’s clients, including those accounts under ERISA or IRA rules and regulations, in
which case the client is acting as either the plan sponsor or IRA accountholder.
Schwab provides Cadaret Grant with access to its institutional trading and custody services, which are typically
not available to Schwab retail investors. These services generally are available to independent investment
advisers on an unsolicited basis, at no charge to them so long as a total of at least $10 million of the advisor’s
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
clients’ assets are maintained in accounts at Schwab Advisor Services. Schwab’s services include brokerage
services that are related to the execution of securities transactions, custody, research, including that in the form
of advice, analyses and reports, and access to mutual funds and other investments that are otherwise generally
available only to institutional investors or would require a significantly higher minimum initial investment.
Schwab generally does not charge separately for custody services for Cadaret Grant client accounts maintained
at Schwab but is compensated by account holders through commissions or other transactions-related or asset-
based fees for securities trades that are executed through Schwab or that settle into Schwab accounts.
Schwab also makes available to Cadaret Grant other products and services that benefit Cadaret Grant but do
not benefit its clients’ accounts. These benefits may include national, regional or Cadaret Grant specific
educational events organized and/or sponsored by Schwab Advisor Services. Other potential benefits may
include occasional business entertainment of personnel of Cadaret Grant by Schwab Advisor Services
personnel, including meals, invitations to sporting events, including golf tournaments, and other forms of
entertainment, some of which may accompany educational opportunities. Other of these products and services
assist Cadaret Grant in managing and administering clients’ accounts. These include software and other
technology (and related technological training) that provide access to client account data (such as trade
confirmations and account statements), facilitate trade execution (and allocation of aggregated trade orders for
multiple client accounts), provide research, pricing information and other market data, facilitate payment of
Cadaret Grant’s fees from its clients’ accounts, and assist with back- office training and support functions,
recordkeeping and client reporting. Many of these services generally may be used to service all or some
substantial number of Cadaret Grant’s accounts, including accounts not maintained at Schwab Advisor Services.
Schwab Advisor Services also makes available to Cadaret Grant other services intended to help Cadaret Grant
manage and further develop its business enterprise. These services include professional compliance, legal and
business consulting, publications and conferences on practice management, information technology, business
succession, regulatory compliance, employee benefits providers, human capital consultants, insurance and
marketing. In addition, Schwab makes available, arranges, and/or pays vendors for these types of services
rendered to Cadaret Grant by independent third parties. Schwab Advisor Services may discount or waive fees
it would otherwise charge for some of these services or pay all or a part of the fees of a third-party providing
these services to Cadaret Grant.
Schwab also reimburses certain Cadaret Grant clients who open an account with Schwab for fees that they
incur to close their accounts with another custodian and open an account and transition their assets to Schwab.
There is a cap on the total fees that Schwab will reimburse each year and Cadaret Grant must transition a
minimum number of new accounts and assets to Schwab to be eligible for the benefit.
While, as a fiduciary, Cadaret Grant endeavors to act in its clients’ best interests, you should expect that Cadaret
Grant’s recommendation that clients maintain their assets in accounts at Schwab may be based in part on the
benefit to Cadaret Grant of the availability of some of the foregoing products and service and other
arrangements and not solely on the nature, cost or quality of custody and brokerage services provided by
Schwab, which creates a conflict of interest.
Review of Accounts
Each IAR monitors his or her client accounts and conducts a review of accounts periodically. Factors that could
result in additional reviews include, but are not limited to, significant market corrections, large deposits or
withdrawals from an account, substantial changes in the value of a client’s portfolio, or a change in the client’s
investment objectives or life circumstances.
In addition to the account reviews conducted by IARs, transactions in APM accounts are subject to review by
the IAR’s designated supervisor through an alert-based electronic transaction review system. IARs are also
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
subject to Cadaret Grant’s branch office examination program where a sampling of accounts and/or
transactions are reviewed by the examiner.
On a periodic basis, clients participating in Cadaret Grant’s sponsored advisory Wrap Fee and Non-Wrap Fee
programs are sent a performance report. The account custodian also sends account statements on a monthly
or quarterly basis. Although the information we provide in the performance reports is obtained from sources
believed to be reliable, we urge you to compare the holdings listed on the custodian’s statement to those listed
on reports Cadaret Grant or your IAR provide. You should carefully review all statements and performance
reports. If any discrepancies are noted, you should contact us at the number on the cover page of this Brochure.
Client Referrals and Other Compensation
IAR Compensation
Cadaret Grant pays your IAR compensation of various types. We compensate our IARs pursuant to
independent contractor agreements. IAR compensation includes a portion of the advisory fee you pay us, which
may be more or less than what your IAR would receive at another advisory firm. An IAR who earns over an
annual threshold amount is eligible for a percentage payout increase on future compensation. In addition, we
offer financial incentives, in the form of cash bonuses and forgivable (“compensatory”) loans, to reward IARs
for increasing their assets serviced or annual revenue. Certain IARs are employed by another financial services
company or individual providing financial services from which these IARs receive a salary or bonus for their
services in addition to their Cadaret Grant compensation. Whenever compensation is based on assets serviced
or annual revenue, an IAR has a conflict of interest and financial incentive to meet those revenue or asset levels
in order to receive increased compensation, including by encouraging you to increase the amount of assets in
your account.
In some cases, we pay a portion of a IAR’s compensation to an IAR’s designated supervisor(s). This creates a
conflict of interest because the compensation affects the designated supervisor’s ability to provide objective
supervision of the IAR. Cadaret Grant and our designated supervisors have an obligation to supervise IARs
and may decide to terminate an IAR’s association with Cadaret Grant based on performance, a disciplinary
event, or other factors. The amount of assets serviced or revenue generated by an IAR creates a conflict of
interest when considering whether to terminate an IAR.
Other Benefits
IARs who meet internal criteria (which includes, but is not limited to, revenue generated from sales of products
and services) are eligible to receive certain benefits pursuant to special incentive programs. These benefits
include eligibility for practice management support and enhanced service support levels that confer a variety of
benefits, conferences (e.g., for education, networking, training, and personal and professional development),
and other non-cash compensation. These benefits also include free or reduced cost marketing materials,
reimbursement or credits of fees that IARs pay to Cadaret Grant for items such as administrative services or
technology, and payments that can be in the form of repayable or compensatory loans (e.g., for retention
purposes or to assist an IAR grow his or her advisory practice). The availability of these benefits presents a
conflict of interest because an IAR has an incentive to recommend to clients our investment products and
services and to remain with Cadaret Grant to receive these benefits.
Recruitment Compensation and Operational Assistance
Cadaret Grant provides recruitment compensation and other financial incentives to IARs transitioning from
other financial services firms to Cadaret Grant. This transition assistance includes payments that are intended
to assist an IAR with costs associated with the transition; however, we do not verify that any payments made
are actually used by an IAR for transition costs. Transition assistance payments can be used for a variety of
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
purposes such as providing working capital to assist in funding the IAR’s business, offsetting account transfer
fees payable to a custodian as a result of clients transitioning to Cadaret Grant’s platforms, technology set-up
fees, marketing, mailing and stationery costs, registration and licensing fees, moving and office space expenses,
staffing support, and termination fees associated with moving accounts.
These payments can be in the form of repayable and/or compensatory loans, and are subject to favorable
interest rate terms, as compared to other lenders. In the case of compensatory loans, the loans are forgiven if
an IAR continues his or her association with Cadaret Grant for a certain period of time or if the IAR meets
other conditions, which can include a requirement to maintain a certain level of assets or generate a certain
amount of revenue at Cadaret Grant. An IARs receipt of a loan from Cadaret Grant presents a conflict of
interest in that the IAR has a financial incentive to maintain a relationship with Cadaret Grant and recommend
Cadaret Grant to clients.
The amount of recruitment compensation provided by Cadaret Grant is often substantial in relation to the
overall revenue earned or compensation received by an IAR at his or her prior firm. Such recruitment
compensation is typically based on a percentage of an IAR's business established at their prior firm, for example,
a percentage of the revenue earned, or assets serviced at the prior firm, or on the size of the assets that transition
to Cadaret Grant. Recruitment compensation provided to IARs does not directly benefit clients. You should
consider the recruitment compensation your IAR receives in evaluating the reasonableness of the compensation
arrangement between you, your IAR, and Cadaret Grant.
Growth Incentives
Cadaret Grant provides financial incentives to reward IARs for increasing their assets serviced or annual
revenue by specific amounts in the form of cash bonuses and compensatory loans.
Conflicts of Interest
A conflict of interest is created when Cadaret Grant provides financial incentives to IARs for moving assets to
Cadaret Grant or increasing their assets serviced or annual revenue at Cadaret Grant. The conflict is due to the
IAR having a financial incentive to maintain his or her relationship with Cadaret Grant, transition assets to
Cadaret Grant, and recommend investment products or services that generate more revenue as compared to
other investments in order to receive a benefit or payment.
We attempt to mitigate these conflicts by reviewing our client accounts and transactions to ensure that we have
a reasonable basis to believe the recommended services and transactions are consistent with a client’s stated
goals, objectives, preferences, and needs and are in a client’s best interest. However, you should be aware of
this conflict and take it into consideration in deciding whether to establish or maintain a relationship with
Cadaret Grant and your IAR. Further information about Cadaret Grant and your IAR’s source of compensation
and conflicts of interest is described in our Brokerage Services Disclosure Summary on our website under
Disclosures (cadaretgrant.com/disclosures/).
Continuing Compensation
Cadaret Grant makes available a program to provide continuing compensation to an IAR’s estate/heirs upon
the IAR’s death or retirement (“inactive IAR”). Continuing compensation includes recurring advisory fees and
brokerage commissions received by Cadaret Grant attributable to accounts established by the inactive IAR
during his or her association with the firm.
To ensure continuity, an IAR names a qualified successor IAR to provide ongoing services to his or her clients.
The successor IAR shares an agreed percentage of the ongoing compensation with the inactive IAR’s
estate/heirs for up to five years. Program eligibility is based on minimum tenure and other qualification
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
standards established by Cadaret Grant.
Other Firm Compensation
As discussed below and elsewhere in this brochure, Cadaret Grant receives compensation, which can be
substantial, from various parties in connection with providing services to clients. In many cases, this
compensation is in addition to any advisory fees that clients pay and is not passed on or credited to clients
unless otherwise noted. When evaluating the reasonability of Cadaret Grant’s fees, a client should not consider
just the advisory fees Cadaret Grant charges, but also the other compensation Cadaret Grant receives.
Indirect Compensation and Revenue Sharing
Cadaret Grant receives compensation and/or fees (also referred to as revenue sharing or marketing support)
from certain mutual fund sponsors (including money market funds), insurance (fixed and variable product)
issuers, UIT, ETF, alternative investment, and structured product sponsors, and unaffiliated investment
advisers that sponsor, manage, and/or promote the sale of certain products that are available to our clients.
Product sponsors and third-party investment advisers (“Partners”) pay this compensation to Cadaret Grant in
what we call our Partners Program.
Partners pay different amounts of revenue sharing fees and receive different levels of benefits for their
payments. These payments can be substantial and, as such, create a conflict of interest for Cadaret Grant
because the payments constitute additional revenue to us and can influence the selection of investments and
services Cadaret Grant and/or our IARs offer or recommend to clients. We seek to mitigate this conflict of
interest by not sharing revenue sharing payments with our IARs. An IAR’s compensation is the same regardless
of whether a sale involves a Partner’s product or service. In some cases, Partners pay additional marketing
payments to Cadaret Grant to cover fees to attend conferences or reimburse expenses for workshops or
seminars. The payments made under the Partners Program are based either on gross sales or assets under
management, or on a flat fee arrangement, and vary by Partner. When Partners pay a flat fee (or marketing
allowance) it is negotiated annually. This payment assists with costs related to education, training, conference
attendance, reimbursement for workshops or seminars and marketing materials for our IARs. We do not share
any marketing allowance with our IARs.
The benefits Partners receive include our IAR contact lists, business metrics, preferred placement on our
website, participation in product training initiatives and marketing and sales campaigns, and the ability to
participate in our conferences.
We use the revenue from our Partners Program to support certain marketing, training, and educational
initiatives including our conferences and events. The conferences and events provide a venue to communicate
new products and services to our registered representatives and IARs, to offer training to them and their support
staff, and to keep them abreast of regulatory requirements. The revenue is also used to pay for annual awards
for our registered representatives and IARs who generate the most revenue overall and to pay for our general
marketing expenses. A Cadaret Grant registered representative or IAR who earns total compensation over a
threshold amount receives an award, in the form of a trophy, medal, or plaque, and is invited to attend Cadaret
Grant’s top producer conference. Revenue from the Partners Program helps to pay for top producer conference
costs. Top producing Cadaret Grant registered representatives and IARs receive an award based on total
revenues, including but not limited to sales of Partners’ mutual funds, annuities, structured products, and ETFs.
We prepare and make available to our IARs a quarterly list of Partners Program mutual funds and ETFs that
have been screened for investment performance against other Partners’ funds with similar objectives and asset
classes (the “Select Fund List” or “List”). Cadaret Grant and our IARs have a conflict of interest when an IAR
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
chooses or recommends an investment from the Select Fund List for your portfolio because Cadaret Grant
receives revenue sharing fees from the mutual fund or ETF sponsor. Our receipt of revenue sharing fees
influences our selection of mutual funds and ETFs, as we are likely to recommend a fund or ETF whose
sponsor pays us revenue sharing fees over a fund or ETF whose sponsor does not pay us.
You do not pay more to purchase funds from the List through Cadaret Grant than you would pay to purchase
these funds through another broker-dealer, and your IAR does not receive additional compensation for
selecting a fund from the List. IARs are not required to choose or recommend investments from the Select
Fund List.
Cadaret Grant also receives compensation from certain unaffiliated or third-party investment advisers
(including certain SMA Managers, Sub-Managers, Strategists, and Model Providers) to assist in paying for
ongoing marketing and sales support activities including training, educational meetings, due diligence reviews,
and day-to-day marketing and/or promotional activities. Not all third-party investment advisers pay such
compensation and participating third-party investment advisers change over time.
The compensation arrangements vary and are generally structured as a fixed dollar amount or as a percentage
of sales and/or assets under management with the adviser.
A conflict of interest exists where Cadaret Grant receives such compensation because there is an incentive to
recommend these third-party advisors over other investment advisers to generate additional revenue for the
firm. However, our IARs are not required to recommend any third-party adviser providing additional
compensation, nor do they directly share in any of this compensation.
Our IARs receive additional compensation from product sponsors. However, such compensation is not tied to
the sales of any products. Compensation includes such items as gifts valued at less than $100 annually, an
occasional dinner or ticket to a sporting event, or reimbursement in connection with educational meetings or
marketing or advertising initiatives, including services for identifying prospects. Product sponsors sometimes
also pay for or reimburse us for the costs associated with education or training events that are attended by our
IARs and for Cadaret Grant-sponsored conferences and events. We also receive reimbursement from product
sponsors for technology-related costs associated with investment proposal tools they make available to our
IARs for use with clients.
To see Cadaret Grant’s Third-Party Fee Disclosure, which identifies the participants in the Partners Program,
along with revenue sharing arrangements by product type, please visit the Disclosures section of our website at
www.cadaretgrant.com/disclosures.
Client Referrals
From time to time, Cadaret Grant and/or its IARs enter into arrangements with clients, third parties or other
financial intermediaries for lead generation, client referrals or solicitation for program accounts (collectively,
“solicitation arrangements”). These solicitation arrangements range from largely impersonal referrals to specific
client introductions to Cadaret Grant and its IARs. Under solicitation arrangements, the third parties and
financial intermediaries are independent contractors. In most cases, third parties are not advisory clients of
Cadaret Grant and do not refer clients based on their experience with Cadaret Grant as advisory clients. The
compensation paid under the solicitation arrangements is structured in various ways, including a one-time fee,
a flat fee per lead or referral, and sharing a portion of the ongoing advisory fee. Cadaret Grant and its IARs
have generally entered referral networks operated by third parties. Referral networks present potential clients
with a list of possible investing firms and investment advisory representatives, or direct potential clients
specifically only to Cadaret Grant and its IARs. Some referral networks receive a flat fee per referral and/or an
ongoing fee, while others share a portion of the ongoing advisory fee.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
Depending on the solicitor’s arrangement with Cadaret Grant, a solicitor may not be compensated for referring
a client who opens a brokerage account rather than an advisory account, and as a result may encourage the
client to open an advisory account instead of a brokerage account. Solicitation arrangements give rise to material
conflicts of interest because the referring party has a financial incentive to introduce new investment advisory
clients to Cadaret Grant and its IARs. Solicitors may also have other conflicts of interest with respect to a
particular IAR or may be associated with Cadaret Grant in another way. Clients who are introduced to Cadaret
Grant and its IARs through a solicitation arrangement receive specific disclosures at the time of the
introduction. If you receive such disclosures, you should review them carefully to understand the details of
Cadaret Grant’s arrangements with the person introducing you to Cadaret Grant. Cadaret Grant’s participation
in these referral arrangements does not diminish its fiduciary obligations to its clients.
Cadaret Grant and its IARs can offer advisory services on the premises of unaffiliated financial institutions, like
banks or credit unions. In such a case, Cadaret Grant will enter into networking agreement with a financial
institution pursuant to which we share compensation, including a portion of the advisory fee, with the financial
institution for the use of the financial institution’s facilities and for client referrals.
Custody
Cadaret Grant has limited custody of our clients’ funds and/or securities when clients authorize us to deduct
our management fees directly from their client’s account. Cadaret Grant is also deemed to have custody of a
client’s funds and/or securities when a client has on file a standing letter of authorization (“SLOA”) with the
account custodian to move money from the client’s account to a third-party and the SLOA authorizes us to
designate, based on your instructions from time to time, the amount or timing of the transfers. Cadaret Grant
also engages in other practices and/or services on behalf of our clients where we are deemed to have custody
of a client’s funds and/or securities, such as our IARs acting as trustees or executors to an estate. Cadaret Grant
complies with the SEC’s Custody Rule including engaging an independent public accountant to verify funds
and securities of which it is deemed to have custody at least once a year.
Cadaret Grant has an arrangement with Custodians to provide clearance and custody of Contour accounts. The
Custodian: (a) maintains custody of all account assets, (b) executes and performs clearance of purchase and sale
orders in accounts, and (c) performs all custodial functions customarily performed with respect to securities
brokerage accounts, including but not limited to the crediting of interest and dividends on account assets. The
Custodian delivers client account statements as well as confirmation of each purchase and sale to you. You can
agree in writing to receive transaction information at least quarterly via a quarterly confirmation report in lieu
of trade-by-trade confirmations. Non-Wrap Fee Contour APM accounts are not eligible to receive the quarterly
confirmation report as this option is only available for wrap fee, discretionary accounts. The Custodian acts as
the general administrator of each account, which includes collecting account fees on Cadaret Grant’s behalf
and processing, pursuant to Cadaret Grant’s instructions, deposits to and withdrawals from the account. The
Custodians do not assist clients in selecting Cadaret Grant or any investment objective or in determining
suitability. You retain ownership of all cash, securities, and other instruments in the account.
You should receive at least quarterly statements from the Custodian. We urge you to compare the holdings
listed on the custodian’s statement to those listed on reports Cadaret Grant or your IAR provide. If you have a
question about a discrepancy, you should direct it to your IAR. If the IAR is unable to adequately address your
concern, you should contact Cadaret Grant at the phone number on the cover page of this Brochure.
Financial Information
Cadaret Grant is not required to include a balance sheet in this Brochure because we do not require or solicit
prepayment of more than $1,200 in fees per client, six months or more in advance.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC
There is no financial condition that is reasonably likely to impair Cadaret Grant’s ability to meet its contractual
commitments to its clients. Cadaret Grant has never been the subject of a bankruptcy proceeding.
Contour Part 2A Appendix 1 Wrap Fee Program Brochure
Rev. 03/28/2025
Cadaret Grant & Co., Inc.
Cadaret Grant & Co., Inc.
Member FINRA/SIPC
Member FINRA/SIPC